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ABSTRACT 
 The present study tested the factor structure of the externalizing disorders 
(e.g. attention-deficit hyperactivity disorder (ADHD), conduct disorder (SE), and 
substance experimentation (SE) ) in adolescence. In addition, this study tested the 
influence of the GABRA2 gene on the factors of the externalizing spectrum. 
Confirmatory factor analyses were used to test the factor structure of the 
externalizing spectrum. Specifically, three competing alternate confirmatory 
factor analytic models were tested: a one-factor model where all disorders loaded 
onto a single externalizing factor, a two-factor model where CD and SE loaded 
onto one factor and ADHD loaded onto another, and a three-factor model, where 
all three disorders loaded onto separate factors. Structural equation modeling was 
used to test the effect of a GABRA2 SNP, rs279858, on the factors of the 
externalizing spectrum. Analyses revealed that a three-factor model of 
externalizing disorders with correlated factors fit the data best. Additionally, 
GABRA2 had a significant effect on the SE factor in adolescence, but not on the 
CD or ADHD factors. These findings demonstrate that the externalizing disorders 
in adolescence share commonalities but also have separate sources of systematic 
variance. Furthermore, biological mechanisms may act as a unique etiological 
factor in the development of adolescent substance experimentation. 
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INTRODUCTION 
Overview 
Comorbidity among psychiatric disorders is a common phenomenon that 
occurs in both epidemiological and clinical samples (Clark, Watson, & Reynolds, 
1995).  Results from the Epidemiological Catchment Survey (ECA; Robins et al., 
1991) showed that 60% of respondents with at least one lifetime DSM disorder 
also had at least one comorbid disorder. Also, the National Comorbidity Survey 
(NCS; Kessler et al., 1994) indicated that the vast majority (79%) of all lifetime 
disorders in a sample of 8098 respondents were comorbid disorders. 
 Data also indicate that comorbidity between disorders is not random; in 
fact, most disorders systematically co-occur with certain diagnostic classes or 
disorders (Clark, Watson, & Reynolds, 1995).  Many possible explanations exist 
for the occurrence of comorbidity. For example, formal models for comorbidity 
between multifactorial disorders proposed by Neale and Kendler (1995) include 
the possibilities that two disorders share the same underlying continuum of 
liability, that one disorder sharply increases risk for developing a second disorder, 
that only extreme cases of one disorder increase risk for developing the second, 
that two disorders are caused by a third, separate disorder, that the risk factors for 
the two disorders are correlated, or that liability for one disorder directly causes 
the second. Understanding and developing these broader conceptualizations of 
psychological disorders can help identify the common etiological or maintaining 
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factors among subsets of disorders and can have important implications for 
clinical diagnosis and treatment.  
The Externalizing Spectrum 
Recently, confirmatory factor analytic (CFA) methods have been used to 
test competing hierarchical models of psychiatric disorders in order to better 
understand comorbidity. This research operates under the assumption that 
psychiatric disorders may be manifestations of latent liabilities that underlie 
putatively unique disorders and this, in turn, may help account for diagnostic 
comorbidity (i.e. shared continuum of liability; Farmer et al, 2009; Krueger et al., 
2002). Findings from such studies have consistently demonstrated that psychiatric 
disorders fall into a hierarchical organizational structure consisting of two higher-
order latent factors, internalizing and externalizing.  Moreover, much research has 
attempted to identify the factor structure of these two higher-order factors.  The 
current study focuses on the structure of the DSM-defined externalizing spectrum 
in adolescence. Broadly, the externalizing spectrum has been conceptualized as a 
general vulnerability dimension underlying and connecting the psychological 
syndromes and personality traits of antisocial behavior, substance dependence, 
impulsivity, and disinhibition (Patrick, Curtin, & Krueger, in press). In terms of 
DSM-IV diagnostic categories, previous research has generally considered the 
externalizing spectrum in adolescence to consist of attention-deficit/hyperactivity 
disorder (ADHD), oppositional defiant disorder (ODD), conduct disorder (CD), 
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alcohol dependence (AD), and drug dependence (DD) (Farmer et al., 2009; 
Krueger & Markon, 2006; Lahey et al., 2008).  
These externalizing disorders in adolescence are a focus of the current 
study for several reasons. Adolescence is a particularly interesting developmental 
period when disruptive behavior disorders and substance use are highly comorbid 
(Lewinsohn et al., 1995), a variety of externalizing problems emerge, and the 
trajectory of individual externalizing behaviors varies considerably (Bongers et 
al., 2004). Additionally, the initiation of certain externalizing behaviors in 
adolescence, such as cigarette smoking and alcohol use, has been shown to 
significantly raise the risk for smoking, alcohol and marijuana use, antisocial 
personality symptoms, and criminality in adulthood (Chassin et al., 1990; Flory et 
al., 2004). Gaining a better understanding of the latent factors that may 
characterize these disorders in adolescence can give us more insight into the 
nosology, etiology, and clinical issues surrounding the externalizing disorders and 
can inform early prevention efforts. 
Evidence for a One-Factor Model of Externalizing Disorders 
Many studies have attempted to model the externalizing spectrum in 
adulthood and adolescence. One well-replicated finding among these studies is 
that a single latent factor best represents the externalizing disorders (Krueger, 
1999; Krueger, Caspi, Moffitt, & Silva, 1998; Vollebergh et al., 2001). It is 
important to note that heterogeneous age ranges were assessed in the studies 
presented here. One such study demonstrated that a hierarchical three-factor 
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structure, characterized by two-lower order factors of a broader internalizing 
factor and a single externalizing factor including AD and DD had the most 
parsimonious fit for data provided by adults in the community (Slade & Watson, 
2006). Krueger and Markon (2006) performed a meta-analysis on published 
multivariate comorbidity models and tested competing alternative models that 
included more than one externalizing factor. The meta-analysis included 
individuals from the ages of 15 into adulthood. Similarly, they found that two 
superordinate factors, internalizing and externalizing, fit the data best. The 
externalizing factor consisted of AD, DD, APD, and CD, and the higher-order 
internalizing factor further bifurcated into two-lower order internalizing factors. 
Vollebergh et al. (2001) replicated these findings in a sample of adults between 
the ages of 18-64 and confirmed that a hierarchical three-factor model fit the data 
best, with one externalizing factor consisting of AD and DD and two internalizing 
factors. Interestingly, Beesdo-Baum et al. (2009) attempted to replicate this 
hierarchical three-factor model in a sample of adolescents and young adults (14-
34 years) and found that although a three-factor model fit the data, the higher-
order ‘internalizing’ factor had to be omitted; thus this study confirms a one-
factor model of externalizing comprised of AD, DD, and APD as well.  
A two-factor model consisting of internalizing and externalizing disorders 
has also been supported in the literature. These studies found that a single 
externalizing factor consisting of AD, DD, and APD in a sample of 15-54 year 
olds (Krueger, 1999), CD, marijuana dependence, and AD at ages 18 and 21 
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(Krueger et al., 1998), and AD, DD, APD, and CD in a sample of adults (Kendler 
et al., 2003) fit the data the best.  
Other studies have attempted to model the externalizing disorders in 
isolation from the internalizing disorders. Young, Stallings, Corley, Krauter, and 
Hewitt (2000) found that the covariation among CD, ADHD, early substance 
experimentation, and novelty seeking in 12-18 year olds were best characterized 
by a single latent factor. A genetically informative modeling study by Hicks, 
Krueger, Iacono, McGue, and Patrick (2004) using symptom counts of CD, adult 
antisocial personality disorder (APD), AD, and DD was suggestive of a single 
underlying externalizing trait in those aged 16-18. Krueger et al. (2002) also used 
symptom counts of CD, adolescent antisocial behavior, AD, DD, and 
disinhibitory personality traits to model the externalizing spectrum with a sample 
of 17 year old twins.  They found that a general factor linked the externalizing 
syndromes, but distinct etiologic factors also differentiated between each 
externalizing syndrome. Furthermore, Krueger et al. (2005) used latent class and 
latent trait models to examine the underlying dimensional structure associated 
with CD, APD, alcohol dependence, and drug dependence in adults. They 
demonstrated that a continuous and normally distributed latent continuum of risk 
best described the externalizing disorders.  
One-Factor Models: Methodological Limitations 
Although a one-factor model of externalizing disorders is a well-replicated 
finding, it is noteworthy that many of the modeling studies reporting a one-factor 
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model of DSM-defined externalizing disorders only examined limited sets of 
externalizing disorders (Krueger et al. 2003; Kendler, Prescott, Myers, & Neale, 
2003). For instance, several studies only included AD and DD in their models 
(Slade & Watson, 2006; Vollebergh et al. 2001) and across other studies, 
inconsistencies emerged in whether marijuana dependence, CD, disinhibition, 
novelty-seeking, and/or APD were included in the models (Krueger et al., 1998; 
Kendler et al., 2003; Young et al., 2000).  
Most of the studies reporting a one-factor model also did not include 
important childhood externalizing disorders such as ADHD. More specifically, in 
all the studies noted above only Young et al. (2000) included ADHD in their 
factor model. This is a major oversight as studies have reported prevalence rates 
of ADHD at 12.8% in preschoolers and between and 8.8-9.0% throughout 
adolescence using diagnoses based on the DSM-IV (Lavigne et al., 2009; 
Merikangas et al, 2010). More importantly, research has identified ADHD 
without symptoms of CD as a risk factor for CD and APD, and consequently, for 
substance use disorders (Biederman et al., 1996; Barkley et al., 2004; Mannuzza 
et al., 2008). ADHD is also highly comorbid with CD (Burt et al., 2001). In order 
to accurately characterize the externalizing disorders, it is important to include 
ADHD in modeling studies.  
The exclusion of these important childhood and adulthood externalizing 
diagnoses is also problematic because evidence has demonstrated that the factor 
structure of common DSM mental disorders may not be stable with the addition 
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of diagnoses (Wittchen et al., 2009). As mentioned earlier, one consistently 
replicated finding is that a hierarchical three-factor model, with one broad 
internalizing factor which bifurcates into two lower-order factors and one 
externalizing factor, best fits data comprised of ten common DSM mental 
disorders (Slade & Watson, 2006; Krueger & Markon, 2006; Vollebergh et al., 
2001; Kessler et al., 1994).  Wittchen et al. (2009) discovered that this 
hierarchical three-factor model no longer provided a robust fit when tested with 
the addition of previously excluded disorders (i.e. ADHD). Therefore, it stands to 
reason that previous studies reporting a one-factor model of externalizing 
disorders may not be entirely accurate due to the exclusion of important childhood 
and adulthood externalizing disorders. 
Although much work has been done to model the externalizing spectrum, 
its structure specifically in adolescence has been less studied. Indeed, a couple of 
the aforementioned studies did include adolescents in their sample (e.g. Young et 
al., 2000; Beesdo-Baum et al., 2009), but these did not include the full range of 
possible externalizing disorders.  Thus, further research that accounts for the 
methodological and conceptual limitations present in many of the studies 
reporting a one-factor model and that examines the factor structure of the 
externalizing disorders in adolescence is warranted.  
Evidence for a Two-Factor Model of Externalizing Disorders 
Although much evidence exists to support one common externalizing 
factor, other studies have shown that there may be distinctions among these 
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disorders as well.  Specifically, researchers have found evidence to support a 
model of externalizing disorders where CD and substance use have some common 
liability that is unique from that of ADHD.  For example, Farmer et al. (2009) 
evaluated four competing alternative models of disorders from the externalizing 
domain which included the DSM-III-R and DSM-IV defined disorders of ADHD, 
ODD, CD, APD, AD, cannabis use disorder (CAN), and hard drug use (HD). 
Importantly, this modeling study included substantially more putative childhood 
and adulthood externalizing disorders in comparison with other similar studies. 
Farmer and colleagues found that a two-factor model fit the data the best, with the 
first factor characterized by ADHD and ODD symptoms like inattention and 
intrusion and the second factor characterized by a general tendency to break rules 
that included CD, APD, AD, CAN, and HD symptoms (coined the ‘social norm 
violation disorders’). Moreover, a plethora of studies have suggested that the 
relation between ADHD and substance abuse disappears once comorbid CD is 
taken into account, while CD remains a significant predictor of substance use 
(Lynskey & Fergusson, 1995; Disney et al., 1999; Flory & Lynam, 2003; August 
et al., 2006). Along the same vein, research indicates that CD, APD, alcohol, 
cannabis, and/or drug diagnoses are best accounted for by a single latent factor 
(e.g. Krueger et al., 2005; Young et al., 2000). A recent article by Beauchaine et 
al. (2010) summarized the potential for protective and high-risk environments to 
differentiate between the development of ADHD-only diagnosis and the 
development of comorbid ADHD, CD, and more severe antisocial personality 
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traits in adolescence. Thus, this review suggests that environmental factors may 
distinguish between ADHD and CD diagnoses. Recent work also suggests that 
ADHD and CD result from distinct primary deficits, with deficits in executive 
inhibition acting as the primary deficit in those with ADHD and reactive 
disinhibitory processes acting as the primary deficit in those with CD (Nigg, 
2003). Taken together, these findings suggest that substance use and conduct 
disorder may share a common liability that is unique from the vulnerability for 
ADHD. 
Need for Replication with Adolescents 
As mentioned previously, adolescence is a particularly important and 
understudied period during which to examine the structure of the externalizing 
disorders. However, the question still remains as to whether a one-factor model of 
the externalizing spectrum would hold with the addition of more putative 
childhood externalizing diagnoses as well as with a sample of adolescents. 
Additionally, although Farmer and colleagues included substantially more 
externalizing diagnoses, no studies have yet looked at whether a two-factor model 
distinguishing ADHD from CD and substance use would hold for a sample of 
adolescents only. Certainly this is an important distinction as Wittchen et al. 
(2009) discovered that the hierarchical three-factor model of disorders described 
above (with a single externalizing factor) did not fit the data robustly when tested 
with more putative disorders and within four age bands of participants aged 1-34 
years. This suggests that, not only might the factor structure of the externalizing 
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disorders vary across ages, but potentially important developmental differences 
may emerge when examined across different age bands. For example, distinct 
substance use factors may not emerge at younger ages due to the lower rates of 
substance use in youth compared to adults. Similarly, factor analyses that include 
ADHD would likely yield different results when assessing different age groups 
because this disorder appears at a higher rate in childhood/adolescence than in 
adulthood (Faraone & Biederman, 2005).  
Genetic Differences Between the ‘Social Norm Violation Disorders’ and ADHD 
Evidence from twin studies and studies using measured genes also 
suggests that genetic differences may exist between ADHD and the ‘social norm 
violation disorders’, providing further substantiation for a two-factor model of 
putative externalizing disorders. For example, Hicks et al. (2004) and Kendler et 
al. (2003) both reported a highly heritable general vulnerability for the social 
norm violation disorders of CD, APD, AD, and DD in two independent twin 
studies. A genome-wide scan also identified a chromosomal region that 
demonstrated linkage to both conduct disorder and adult alcohol dependence 
(Dick et al., 2003).  Furthermore, Comings et al. (2000a; 200b) demonstrated that 
CD may be genetically distinct from ADHD.  
Taken together, these findings suggest that genetic distinctions exist 
between these two factors. However, no studies have yet looked at which 
particular genes might account for this difference. Taking this next step will be 
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crucial in order to further understand the comorbidity between and etiology of the 
externalizing disorders.  
The Role of the GABA System in Externalizing Disorders 
 A multitude of genes and their associated neurotransmitter systems have 
been associated with externalizing disorders. One particularly promising avenue 
to explore in differentiating between the social norm violation and ADHD is the 
GABA system. GABA acts as the vertebrate brain’s main inhibitory 
neurotransmitter (Barnard et al. 1998), and GABAA receptors undergo allosteric 
modulation by a variety of drugs such as ethanol, benzodiazepines, barbituates, 
and anesthetics (Enoch, 2008). Studies have suggested that GABA plays a 
mediating role in the relationships between ethanol consumption and anxiolysis, 
sedation, motor coordination, and ethanol tolerance and dependence (Buck, 1996; 
Grobin et al. 1998; Korpi, Makela & Uusi-Oukari, 1998). Animal studies have 
also demonstrated that GABAA agonists increase ethanol intake in rats and 
GABAA antagonists decrease ethanol intake in rats (Boyle et al. 1993; Tomkins & 
Fletcher 1996; Nowak et al. 1998). GABAergic interneurons within the ventral 
tegmental area (VTA) are also primarily responsible for the inhibitory regulation 
of dopamine neurons (Johnson and North, 1992; Steffensen et al., 1998). 
Importantly, the dopamine system has long been identified as the “reward” 
pathway which influences a variety of compulsive, impulsive, and addictive 
behaviors. Thus, via its regulatory functions over the dopamine system, the 
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GABA system is also thought play a role in compulsive and addictive behaviors 
such as substance use, CD, and ASPD (Comings & Blum, 2000).   
 Candidate gene family studies have also found associations between 
chromosome 4p (region where some GABA genes are encoded) and alcoholism 
(Reich, 1996; Reich et al., 1998; Song et al., 2003). Moreover, chromosome 4p 
displayed linkage to brain oscillations in the β frequency band of the 
electroencephalogram (13–28 Hz; EEG-β), which is a biological endophenotype 
that has been found to have increased power in alcoholics compared to controls 
(Costa and Bauer 1997; Rangaswamy et al. 2002) and in the offspring of male 
alcoholics (Bauer and Hesselbrock 1993; Rangaswamy et al. 2004). Another 
biological endophenotype, P300 response, is an event-related potential that is 
highly heritable and also showed evidence of linkage with chromosome 4 (Dick et 
al., 2006). Notably, reduced P300 amplitude has been associated with conduct 
problems in adolescents (Bauer & Hesselbrock, 1999), antisocial personality 
disorder and alcohol dependence (Costa et al., 2000) and later substance use 
disorders (Habeych et al., 2005). Through associations with these biological 
endophenotypes, researchers have posited that the genes on chromosome 4 play a 
role in the general externalizing spectrum of disorders.  
Evidence linking GABRA2 to the Externalizing Spectrum 
Of the four genes found on chromosome 4p, Edenberg et al. (2004) 
discovered that only the GABRA2 gene was significantly associated with 
alcoholism in a sample of families with multiple alcoholic members assessed in 
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the Collaborative Study on the Genetics of Alcoholism (COGA). Furthermore, 31 
of the 49 single-nucleotide polymorpisms (SNPs) in GABRA2 were significantly 
associated with alcoholism, while only 1 of the 20 SNPs in the other three genes 
on chromosome 4p were significantly associated, which is a level that reflects 
chance. Further analyses showed that the region extending from intron 3 past the 
3’ end of the GABRA2 gene had the strongest associations with alcoholism.  
Using different samples and study designs, several studies have since 
replicated the initial finding from the COGA study demonstrating that GABRA2 
is associated with alcoholism. Covault et al. (2004) found significant associations 
between alcoholism and seven adjacent SNPs on the GABRA2 gene, many of 
which were the same SNPs reported by Edenberg and colleagues. This group also 
detected the strongest associations with alcohol dependence in the 3’ region of the 
GABRA2 gene. Two case-control studies by Lappalainen et al. (2005) and Fehr et 
al. (2006) examined this effect in Russian alcoholic men and controls and German 
alcoholics and controls, respectively. They both found significant associations of 
SNPs in the 3’ region of the GABRA2 gene with alcohol dependence.  
In addition to associations with alcohol dependence, GABRA2 has also 
been linked to a spectrum of externalizing disorders such as drug dependence, 
nicotine dependence, conduct disorder and antisocial personality disorder. 
Agrawal et al. (2006) reported associations between SNPs in the GABRA2 gene 
and marijuana and illicit drug dependence in the COGA sample. Interestingly, 
their results showed that GABRA2 was most strongly associated with comorbid 
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alcohol and drug dependence. The association between GABRA2 and illicit drug 
dependence was also replicated by Dick et al. (2006) with a sample of individuals 
from control families in the COGA study. Despite the lower rates of drug 
dependence in this sample, the magnitude of the genotype effect was similar to 
that found with the entire COGA sample. Drgon et al. (2006) found evidence of 
association between SNPs in the GABRA2 gene and polysubstance abuse in a 
sample of European American polysubstance abusers and controls. They also 
found that a haplotype of GABRA2 was present at significantly different allelic 
frequencies in African American polysubstance abusers compared to controls. 
Additionally, a case-control study consisting of nicotine-dependent cases and non-
dependent smoking controls found that haplotypes of GABRA2 were associated 
with nicotine dependence (Agrawal et al., 2008).  
Dick et al. (2006) also reported a significant association between the 
rs279871 SNP in GABRA2 and conduct disorder in a sample of children and 
adolescents. Specifically, those homozygous for the risk allele (A), which was 
also associated with alcohol dependence in the adult COGA sample, were 
significantly more likely to meet for a diagnosis of conduct disorder than those 
who were not homozygous for the A allele. Findings from the COGA study also 
revealed a higher rate of antisocial personality disorder in those with the high-risk 
GABRA2 genotype compared to those with the low-risk genotype; this finding 
was later replicated in an independent control sample as well (Dick et al., 2006). 
Clearly, GABRA2 is a strong contender to consider in elucidating the genetic 
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underpinnings of the externalizing spectrum, and more specifically, the social 
norm violation disorders of CD and substance use.  
Developmental Considerations for the Influence of GABRA2 
Recent evidence has emerged to suggest that GABRA2 may influence the 
‘social norm violation disorders’, such as CD, AD, and DD, differentially across 
development. Dick et al. (2006) discovered that having one copy of the risk allele 
(A) in the rs279871 SNP of GABRA2 conferred risk for conduct disorder in those 
aged 7-17. Between the ages of 15-20, individuals possessing one copy of the risk 
allele had consistently elevated rates of alcohol dependence. Before the age of 15 
and between the ages of 20-mid-20’s individuals possessing the risk allele did not 
evidence significantly higher rates of alcohol dependence compared to those 
without the risk allele. The researchers posited that GABRA2 may not have been 
associated with alcohol dependence before the age of 15 because evidence 
suggests that the environment has a much greater influence than genetic factors on 
initiation of alcohol use in early adolescence and not many individuals had 
alcohol dependence at that time (Rhee et al., 2003; Rose et al., 2001). 
Additionally, the relation between GABRA2 and alcohol dependence may have 
been obscured, or diminished, between the ages of 20-mid-20’s by the rise in 
alcohol use and/or dependence as individuals reached legal drinking age. 
Consistent with previous findings, as these participants reached their mid-20s the 
GABRA2 risk allele was again associated with increased incidence of alcohol 
dependence. 
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 In the same study, GABRA2 was found to be associated with illicit drug 
dependence in adolescents after the age of 15 and through adulthood, which 
stands in contrast to the observed developmental trajectory between GABRA2 
and alcohol dependence. This could be due to the fact that drug experimentation is 
a less normative behavior and may not be influenced by environmental factors, 
such as legal age of initiation, as may be the case with alcohol use (Dick et al., 
2006).  
Taken together, this evidence suggests that adolescence may be a 
developmental period during which GABRA2 has a distinct effect on all the 
“social norm violation disorders” of AD, DD, and CD. In other words, GABRA2 
may have a particularly robust influence on the latent factor of the social norm 
violation disorders in adolescence. Yet, this is not to say that GABRA2 does not 
have important effects on this latent factor at other developmental stages. Note 
that, because the current study will assess the externalizing spectrum in 
adolescence, APD has not been included in this discussion as it is a disorder that 
can only be diagnosed in adulthood (after the age of 18 years).  
The Potential Distinct Role of GABRA2 with the Social Norm Violation Disorders 
vs. ADHD 
Thus far, all the work with the GABRA2 polymorphism has focused on 
associations with the social norm violation disorders. Given the proliferation of 
candidate gene studies, particularly with GABRA2, and the high heritability of a 
single externalizing factor, it is surprising that a paucity of research has been 
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published examining the relation between GABRA2 and ADHD. That the relation 
between GABRA2 and ADHD has not been established yet warrants further 
research. This, in combination with recent evidence for a two-factor model and 
the association between GABRA2 and the social norm violation disorders, could 
suggest that GABRA2 plays a role in distinguishing the social norm violation 
disorders and ADHD in adolescence. However, it is important to recognize that 
GABRA2 could represent just one of multiple genes that may distinctly underlie 
the social norm violation disorders. Moreover, ADHD and the social norm 
violation disorders may well share common, as well as distinct, genetic 
underpinnings. Thus, although GABRA2 may be a good candidate with which to 
examine the distinct genetic bases of some externalizing disorders, by no means is 
it the only important gene to consider or would it provide evidence for the 
complete differentiation between the two hypothesized factors. 
The Current Study 
Thus, the current study sought to test a two-factor model of externalizing 
disorders where substance use and conduct disorders load onto the same factor 
(social norm violation disorders) and ADHD loads onto a separate factor in 
adolescence. This model will be tested against two competing alternate 
hypotheses: that a one-factor model including all three disorders fits the data best, 
and that a three-factor model, where each disorder loads onto its own factor, fits 
the data best. Additionally, this study aimed to extend the current literature by 
testing whether a SNP in the GABRA2 gene significantly predicts the 
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hypothesized ‘social norm violation’ factor, and does not significantly predict the 
ADHD factor in adolescence. Furthermore, if the competing alternate models fit 
the data better, this research sought to examine the relation of the GABRA2 SNP 
to the factors in each model. 
This study is the first, to our knowledge, to test and replicate the two-
factor model of externalizing disorders with a sample of adolescents. Although 
previous studies have suggested that the social norm violation and ADHD may 
have distinct genetic underpinnings, this study will take the novel approach of 
examining whether a specific gene, GABRA2, accounts for these differences in 
adolescence. Importantly, this research draws on previous literature that shows 
that the effects of GABRA2 may be developmentally sensitive and thus, may 
have a distinct effect on the latent factor of the social norm violation disorders in 
adolescence. The findings will expand our understanding of the factor structure of 
the externalizing disorders in adolescence. Moreover, identifying the genes that 
influence the latent factors inherent in the externalizing disorders may prove 
helpful in uncovering the etiology of this class of disorders during the critical 
developmental period of adolescence.   
METHOD 
The Original Study 
Participants 
Participants for the current study are drawn from a longitudinal study of 
familial alcoholism (Chassin, Flora, & King, 2004; Chassin, Pillow, Curran, 
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Molina, & Barrera, 1993; Chassin, Pitts, DeLucia, & Todd, 1999). To date, six 
waves of data have been collected. Wave 1 began in 1988, Wave 2 in 1989, Wave 
3 in 1990, Wave 4 in 1995, Wave 5 in 2000, and Wave 6 in 2006. 
The total sample at Wave 1 consisted of 454 adolescents and their parents. 
In this study, the original adolescents are referred to as G2s and the parents are 
referred to as G1s. Of these G2 adolescents 246 were children of alcoholics 
(COAs), which means that at least one of their G1 biological parents, who was 
also a custodial caregiver, was an alcoholic. The remaining 208 G2 adolescents 
were demographically matched controls who did not have any G1 biological, 
custodial parents who were alcoholics. These adolescents (G2s) and their parents 
(G1s) were interviewed for three consecutive years (Waves 1, 2, and 3) after 
initial contact.  
Waves 4, 5, and 6 were long-term follow-ups that began when the G2 
adolescents reached emerging adulthood.  In addition to the original 454 G2 
adolescents, full biological siblings of both COAs and non-COAs were 
interviewed in Waves 4, 5, and 6. The added siblings are also referred to as G2s. 
Specifically, 327 G2 siblings were added at Wave 4 and 50 more siblings were 
added at Wave 5. Sample retention was excellent, with 407 (90%) of the original 
454 G2 participants remaining in Wave 4, and 412 (91%) remaining in Wave 5. 
Of the 327 G2 siblings added in Wave 4, 300 (92%) were retained in the study at 
Wave 5. At Wave 6, 816 (90%) of the G2s were retained in the study and 745 
  
20 
 
G3s, or children of G2s, were added to the study. Currently, an 18-month follow-
up data collection is being conducted with the G3 participants.  
Recruitment 
COA families 
 Several recruitment methods were utilized to obtain the participants in this 
study. Initially, court records, health maintenance organization wellness 
questionnaires, and community telephone surveys were used to recruit COA 
families. Records obtained from seven different court systems identified 
individuals who were convicted of driving while intoxicated between the years of 
1984 and 1988. Inclusion criteria were non-Hispanic Caucasian or Hispanic 
ethnicity, Arizona residency, and a birth-date between 1927 and 1960. These 
court records were also used to determine indicators of alcoholism, which varied 
by court system. Depending on the court system, indicators of alcoholism 
included a blood alcohol content of at least .15 at the time of arrest, past alcohol-
related arrests, a score of seven or higher on the Michigan Alcohol Screening Test 
(MAST; Selzer, 1971), or a diagnosis of probable alcoholism by a court substance 
abuse screening center. Using these records, the study recruited 103 COA 
families. 
 In addition to records from the court system, participants were recruited by 
examining HMO wellness questionnaire responses of those who joined a large 
HMO between 1986 and 1988. These new members who were arrested between 
1984 and 1988 and met the previously mentioned inclusion criteria were then 
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assessed for multiple indicators of alcoholism including consuming 26 or more 
alcoholic drinks per week, reporting three or more alcohol-related social 
consequences, or self-labeling as an alcoholic. An additional 22 COA families 
were recruited using this method. Community telephone surveys were also used to 
recruit participants. Individuals who endorsed the aforementioned demographic 
criterion were then screened for alcoholism with the following indicators: being 
hospitalized for a drinking problem, reporting that their spouse was an alcoholic, 
or attending an Alcoholic Anonymous meeting. One-hundred twenty additional 
COA families were recruited with these telephone surveys. In addition, one COA 
family was recruited at the Veteran’s Administration outpatient treatment 
program. Finally, 80 families who had initially been recruited as demographically 
matched controls were re-categorized as COA families after in-person interviews 
revealed the presence of parent alcoholism. 
 Following these initial screening and recruitment efforts, parental 
alcoholism diagnoses were verified face-to-face with the DIS-III, which is a 
structured diagnostic interview that allows for DSM-III diagnoses of lifetime 
alcohol abuse or dependence (Robins, Helzer, Croughan & Ratcliff, 1981). These 
interviews were conducted with the identified alcoholic parent unless he/she 
refused to participate; if so the refusing parent was diagnosed using their spouse’s 
report on the Family History-Research Diagnostic Criteria (FH-RDC; Endicott, 
Andreason, & Spitzer, 1975). These structured interviews revealed that 219 
biological fathers and 59 biological mothers met criteria for DSM-III alcoholism.  
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Non-alcoholic demographically matched control families 
 Recruitment of matched controls was achieved by using reverse 
directories to identify families who lived in the same neighborhood as COA 
families. Control families were matched on several variables including the 
original adolescent’s age (within one year), family composition (one- vs. two-
parent household), ethnicity, and socioeconomic status (based on property value 
codes or parental income). In order to be in the control group, neither the 
biological or custodial parents could meet DSM-III or FH-RDC lifetime diagnosis 
of alcohol abuse or dependence. However, the control group was not screened for 
any other DSM diagnoses in order to participate. Seventeen control families were 
eliminated from the study because they reported indicators of alcohol problems 
that were approaching the diagnostic threshold. This measure was taken in order 
to decrease the chances that a control parent would be diagnosed as an alcoholic 
at a later point in the project. 
Recruitment biases  
 Two main sources of potential recruitment bias exist for this study: not all 
the potential COA participants were contacted and some individuals contacted 
refused to participate (Chassin, Barrera, Bech, & Kossak-Fuller, 1992). The 
potential bias of selective contact with potential COA participants was addressed 
by comparing the HMO and court archival records of the participants who were 
and were not contacted. Chi-square and t-test analyses demonstrated no 
significant differences between these two groups on blood alcohol level at the 
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time of arrest, self-labeling as an alcoholic, the number of prior alcohol-related 
arrests, or MAST scores. However, these analyses revealed that the non-contacted 
potential participants were more likely than contacted participants to be younger 
(37 vs. 39 years old), from court sources (90% vs. 87%), of Hispanic ethnicity 
(22% vs. 39 %), unmarried (64% vs. 48%), and to have a lower SES rating 
associated with their residence (t-tests and chi-square comparisons significant at 
p<.05). 
 Refusal to participate was the second source of recruitment bias. Of the 
potential COA families who were contacted through telephone surveys, 73% of 
the COA families and 77% of the control families participated. The remaining 
families who refused to participate did not differ from the non-refusers on 
alcoholism indicators, age, sex, or SES ratings. However, refusers were more 
likely to be Hispanic (24% vs. 18%) and married at the time of their arrest (69% 
vs. 50%). Of the potential matched control families, 91 families provided 
demographic information during the initial phone screen but ultimately refused to 
participate. Therefore, refusal bias in the matched control sample was assessed by 
comparing the control families who agreed to participate against those who 
refused. No significant differences emerged between the two groups in family 
composition or SES ratings of their residences. However, significant differences 
were found between the two groups with respect to ethnicity. Specifically, both 
mothers and fathers who refused to participate were more likely than non-refuser 
mothers and fathers to be Hispanic (41% vs. 18% and 40% vs. 22%, respectively). 
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Procedure 
 At each wave, consent and assent to participate were provided by parents 
and children. Subsequently, the families were interviewed either at the family’s 
residence or at the Arizona State University campus. Trained staff members 
conducted all interviews by reading items verbally from a laptop computer. The 
participants had a choice between entering their responses directly into the laptop 
computer or responding verbally and allowing interviewers to enter their data. 
Family members who arrived to the session together were interviewed in separate 
rooms in order to increase the privacy and confidentiality of their responses. 
These interview sessions lasted between 1-2 hours and each family was paid $50 
for their participation. Additionally, at Wave 6 G2s and G3s were given the 
option to participate in DNA testing. Participants could decline participation in 
this portion without consequences. G2s who agreed to participate provided 
consent and G3s who agreed to participate provided assent and received consent 
from the G2 guardian. They then provided a cheek brushing sample or saliva 
sample and were paid an additional $15 for their participation. 
The Current Study 
Participants 
 Two subsets of participants were used in the study. The first subsample of 
participants was used for the modeling of the externalizing spectrum and include 
those G2s who were between the ages of 12-18 years at waves 1, 2, and 3, were 
either of non-Hispanic Caucasian or Hispanic ethnicity, and had no missing data 
  
25 
 
on self-reported ADHD, CD, and substance use at all three waves (N=302). The 
second subsample of participants was used to determine whether there were 
genetic effects on the externalizing spectrum and include those G2s who were 
between the ages of 12-18 years at waves 1, 2, and 3, were successfully 
genotyped, were either of non-Hispanic Caucasian or Hispanic ethnicity, and had 
complete data on self-reported externalizing behaviors and substance use 
(N=138). A small percentage of the original sample (4.9%) self-reported as an 
ethnicity other than non-Hispanic Caucasian or Hispanic. These participants were 
dropped in order to avoid problems relating to population stratification. 
Descriptive data for the first subsample follow. The mean age was 13.80 years 
(SD=1.03) at wave 1, 14.74 years (SD=1.03) at wave 2, and 15.74 years 
(SD=1.04) at wave 3. The total mother-reported family mean income in the first 
subsample over the three waves ranged from approximately $39,423 - $39,679,  
47% were female, 73.5% self-identified as non-Hispanic Caucasian, and 26.5% 
self-identified as Hispanic. More than half of the G2’s mothers’ (56%) and 
fathers’ (57.8%) had at least some college education at wave 3 and 52.6% of the 
G2s were identified as children of alcoholics (COAs). Descriptive data for the 
second subsample (those who were also genotyped) follows. The mean age was 
13.77 years (SD=1.04) at wave 1, 14.70 years (SD=1.05) at wave 2, and 15.70 
years (SD=1.06) at wave 3. The total mother-reported family mean income in the 
first subsample over the three waves ranged from approximately $37,766 - 
$39,7570,  50.7% were female, 72.5% self-identified as non-Hispanic Caucasian, 
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and 27.5% self-identified as Hispanic. More than half of the G2’s mothers’ 
(56.4%) and fathers’ (54.5%) had at least some college education at wave 3 and 
52.9% of the G2s were identified as children of alcoholics (COAs). 
 A series of analyses were conducted to determine if any differences were 
evident between the G2s at Wave 3 who were included in the first and second 
subsamples versus those who were excluded. The participants were compared on 
all proposed variables in the model including gender, age, ethnicity, COA status, 
highest level of parent education, child report of externalizing behaviors, and 
child-report of own substance use. The first subsample (N=302) had significantly 
higher CD symptoms at waves 1 (t(447)=-3.29, p=.001, Cohen’s d=.33), 2 
(t(444)=-3.57, p<.001, Cohen’s d=.36) and 3 (t(432)=-2.6, p=.01, Cohen’s d=.27), 
ADHD symptoms at wave 1 (t(450)=-2.21, p=.028, Cohen’s d=.22), number of 
substances used at wave 3 (t(307.6)=-2.42, p=.016, Cohen’s d=.24), and age at 
waves 1 (t(230.7)=-13.11, p<.001, Cohen’s d=1.45), 2(t(219.6)=-12.94, p<.001, 
Cohen’s d=1.46), and 3 (t(214.3)=-13.29, p<.001, Cohen’s d=1.51) compared to 
excluded participants. The two groups also differed significantly on ethnicity 
(χ2(4)=49.41, p<.001, Cohen’s Omega=.40). These differences are likely due to 
the age and ethnicity exclusion criteria that defined the first subsample. The 
second subsample (N=138) did not differ significantly from the excluded 
participants on the aforementioned variables except the second subsample had 
significantly higher age at waves 1 (t(371.3)=-6.36, p=.001, Cohen’s d=.56), 2 
(t(370)=-6.18, p=.001, Cohen’s d=.55), and 3 (t(369.3)=-6.24, p=.001, Cohen’s 
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d=.56) compared to excluded participants, and the two groups differed 
significantly on ethnicity (χ2(4)=11.25, p=.024, Cohen’s Omega=.29). See Tables 
1 and 2 for further details.  
Measures 
 The measures used in the current study were administered as part of a 
larger interview battery administered in the longitudinal study described above. 
Descriptive statistics for the variables in the first and second G2 subsamples are 
presented in Tables 3 and 4. 
Adolescent Demographics 
 Adolescents self-reported their gender and age. Gender was dummy 
coded, with females coded 0 and males coded 1. A continuous age variable was 
computed for each adolescent as the number of years between their date of birth 
and their interview date. Age at wave 3 was used for the analyses because there 
was greater variability compared to age reports at wave 1. Adolescents self-
reported on their ethnicity using the following options: Non-Hispanic Caucasian; 
Hispanic; Asian, Oriental, or Pacific Islander; American Indian; Black or Afro-
American; or Other. 
Parental Education and Total Family Income 
 Mothers and fathers reported on the highest level of education they 
received. The response options were as follows: 1 (grade school), 2 (some high 
school), 3 (high school graduate), 4 (technical school), 5 (some college), 6 
(college graduate), and 7 (graduate school/professional school).  The highest level 
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of education obtained by either mother or father at wave 3 was used as an 
indicator of socioeconomic status (SES).  If this indicator of SES was missing at 
wave 3, then wave 2 or wave 1 SES was used. Mothers and fathers were also 
asked to report their total family income; there were no response options for this 
item. 
Adolescent ADHD and CD  
 Adolescent ADHD and CD symptom counts during the past 3 months 
were assessed using the Child Behavior Checklist (CBCL; Achenbach, 1978) at 
all three waves. The CBCL was administered to adolescents and consisted of 40 
items. This measure contains four subscales of adolescent symptomatology: 
internalizing, externalizing, aggression, and hyperactivity. The externalizing and 
aggression subscales also included Achenbach youth-self report items that were 
modified to match the CBCL item formats. The adolescents rated how often each 
item has been true of them in the past three months (e.g. “I argued a lot,” “I 
disobeyed at school” “I stole things at home,” “I threatened to hurt people”). 
These items were scored on a three-point Likert scale: 0 (not true), 1 (somewhat 
or sometimes true), or 2 (very true or often true).  However, in the original 
longitudinal study the response scale for the adolescent self-report was modified 
to a five-point Likert scale in order to increase the variance of the adolescent’s 
scores and to eliminate the confounding effects of frequency and intensity in a 
single response scale. Each item in the modified adolescent self-report battery was 
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scaled accordingly: 0 (almost never), 1 (once in a while), 2 (sometimes), 3 (often), 
or 4 (almost always). 
 For the purposes of the current study, each item in the adolescent-version 
was re-scaled to the original three-point scale. The modified options of ‘1’ (once 
in a while) and ‘2’ (sometimes) were collapsed to represent the original scale 
option of ‘1’ (somewhat or sometimes true) and the modified options of ‘3’ 
(often) and ‘4’ (almost always) were collapsed to represent the original scale 
option of ‘2’ (very true or often true). The response option ‘0’ (almost never) 
remained the same.  
 Selected items from the CBCL can be scored according to DSM-oriented 
subscales, which were constructed by panels of expert psychiatrists and 
psychologists who identified the CBCL items that closely reflected DSM-IV 
criteria. In the current study, we used these criteria to construct DSM-oriented 
symptom scales of ADHD and CD. Seven of the 22 items could not be assessed 
because they were not included in the 1978 version of the CBCL. To compute 
symptom scales, items from each subscale (response options from 0-2) were 
summed. Thus in this study, child-report of ADHD consisted of 4 items and 
scores ranged from 0-8 and CD consisted of 12 items and scores ranged from 0-
24.  
The CBCL is one of the most widely used measures of 
behavioral/emotional problems in children with established reliability and 
predictive validity (Runyan et al., 1998). Good internal consistencies have been 
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reported for the adolescent’s self-report (Cronbach’s Alpha ranging from .70-.86), 
and the measure has been demonstrated as a reliable indicator of child conduct, 
oppositional defiant, and aggressive behaviors (Achenbach & Rescorla, 2001). 
Good test-retest correlations have also been established for the subscales of the 
adolescent’s self-report (.82-.88 over 8 days). In the current study, internal 
consistencies for the subscales of ADHD and CD ranged from .65-.79 for 
adolescent-report across the three waves and two subsamples. Only one reporter 
was chosen in order to maintain consistency (substance use was only reported by 
adolescents, see below) and to retain a sufficient sample size for the analyses.  
Adolescent Substance Experimentation 
 Adolescents self-reported their substance experimentation by responding 
to items from a questionnaire adapted from a previous measure by Sher et al. 
(1987).  The measure by Sher et al. (1987) was originally adapted from 
questionnaires by Blane (1987) and Jessor & Jessor (1973). Nine items assessed 
how often in the past year the adolescent typically: got drunk on alcohol, used 
marijuana, amphetamines, quaaludes or barbituates, tranquilizers, hallucinogens, 
cocaine or crack, opiates, or inhalants. Responses were scaled on an 8-point 
Likert scale (0=never to 7=everyday). Alcohol use was defined as whether the 
adolescent had “gotten drunk” in order to capture a more severe group of 
substance-users.  
Adolescent substance experimentation for each wave was defined as the 
number of substances the adolescent used (at least one time) in the past year. 
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Their responses were then categorized into three groups with 0 indicating never 
having tried any substances in the past year, 1 indicating having tried 1 substance 
in the past year, and 2 indicating having tried 2 or more substances in the past 
year. There were no overlapping items between the items on the DSM-oriented 
subscales from the CBCL and the substance use items, so no items were deleted.  
GABRA2 
Genotyping was done through the Washington University Genome 
Sequencing Center of the Midwest Alcohol Research Center (MARC) with 
assistance from a bioinformatician from the Division of Human Genetics. The 
SNPS were scored using Illumina’s Assay Design Tool to ensure designability. 
After genotyping was complete, the following quality control analyses were 
conducted: (1) cluster plots were examined to rule out ambiguous genotype calls; 
(2) checks for Mendelian inconsistencies, incorrect gender assignments and 
sample swaps, and cryptic relatedness were conducted and appropriate corrections 
were made; (3) SNPs with low call rates (< 95%) and deviations from Hardy-
Weinberg equilibrium (p < 10-6) were flagged. A SNP from the GABRA2 gene 
was used in the analysis. This SNP, rs279858, encodes a silent polymorphism in 
exon 5 of the GABRA2 gene and has two alleles, G and A. The GABRA2 SNP 
was coded with a series of dummy codes. These dummy codes compared the AA 
homozygote genotype to the AA and GG genotypes. Another series of dummy 
codes was used to compare the AA and GG genotypes. The SNP was in Hardy-
Weinberg equilibrium (p=.64) and had excellent call rates (98.385%). Among 
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self-identified non-Hispanic Caucasians, 68.0% (N=68) possessed at least one 
copy of the G allele and the minor allele frequency (MAF) was 40%. Among self-
identified Hispanics, 65.8% (N=25) possessed at least one copy of the G allele 
and the minor allele frequency (MAF) was 36%. 
Population stratification occurs when non-random mating among sub-
groups results in systematic differences in allele frequencies between sub-groups 
in the sample. This phenomenon poses a threat to the internal validity of genetic 
association studies (Cardon & Palmer, 2003). Based on the non-significant 
correlation between ethnicity and the GABRA2 SNP (r=-.034, p=.70), we 
concluded that population stratification was not a threat to the internal validity of 
the study. 
DATA ANALYTIC STRATEGY 
Confirmatory Factor Analyses 
Three competing alternative models (one-, two-, and three-factor models) 
of the externalizing spectrum were tested using CFA. The hypothesized model 
bifurcates into two correlated factors. The first factor consists of six indicators: 
conduct disorder symptom counts and substance experimentation at waves 1, 2, 
and 3. The second factor consists of three indicators: ADHD symptom counts at 
waves 1, 2, and 3. The next model that was tested was the one-factor model of 
externalizing. This single latent factor was indicated by ADHD and CD symptom 
counts and substance experimentation at waves 1, 2, and 3. The last model tested 
was a three-factor model of externalizing. This model had three correlated latent 
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factors of CD (indicated by CD symptom counts at waves 1, 2, and 3), ADHD 
(indicated by ADHD symptom counts and waves 1, 2, and 3), and substance 
experimentation (indicated by substance experimentation at waves 1, 2, and 3). 
See Figures 1 and 2 for a pictorial summary of the three competing models.  
The WLSMV estimator was used because the dependent variables were 
continuous and ordered categorical. The WLSMV estimator produces weighted 
least square parameter estimates using a diagonal weight matrix with standard 
errors and mean-and variance- adjusted chi-square test statistic that use a full 
weight matrix (Muthén & Muthén, 1998-2007). The models were evaluated using 
an omnibus chi-square test of global model fit. This is used to test the null 
hypothesis that the model fits exactly in the population. Researchers typically 
consider an acceptable chi-square goodness of fit test statistic to be one whose p-
value is above .05 (Saris, Satorra, & van der Veld, 2009). In addition, the models 
were assessed for goodness of fit based on whether the values of the following fit 
indices were in line with recommendations made by Hu & Bentler (1999): 
Comparative Fit Index (CFI): ≥.95, and Root Mean Square Error of 
Approximation (RMSEA) ≤ .06, and by Muthén & Muthén (2006): Weighted 
Root Mean Square Residual (WRMR) <.90. Furthermore, to study sources of lack 
of fit in case of an overall misfit, model residuals and model modification indices 
were examined. 
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Structural Equation Modeling 
 Depending on the best-fitting model, structural equation modeling was 
used to determine the effect of GABRA2 on the externalizing spectrum. Thus, if 
the hypothesized two-factor model fit the data better than the one-or three- factor 
models of externalizing disorders, both latent factors were regressed on the 
GABRA2 SNP in the structural equation modeling framework to test the 
hypothesis that GABRA2 significantly predicted one factor (indicated by CD and 
substance experimentation) in the two-factor model and not the second factor 
(indicated by ADHD). However, if the one- factor model of externalizing 
disorders fit the data better than a two-or three factor model, the effect of 
GABRA2 on the single latent externalizing factor was tested by regressing the 
externalizing latent factor on the GABRA2 SNP. Lastly, if the three-factor model 
fit the data best, the effect of GABRA2 on each of the three latent factors was 
tested by regressing each latent factor on the GABRA2 SNP. Paths were 
considered significant at p<.05. 
Covariates and Covariate by Predictor Interactions 
 In addition to testing the effect of the GABRA2 SNP, the structural 
equation models also tested the effects of covariates and covariate-by-predictor 
interactions. Covariates were included to increase the power and sensitivity of the 
test by minimizing uncontrolled variability, and therefore to account for some 
variance that would otherwise be considered error (Cohen et al., 2003). 
Preliminary analyses were conducted to determine which covariates to include in 
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the final models.   The continuous predictors were centered in order to reduce 
non-essential multicollinearity in analyses that include interaction terms (Cohen, 
Cohen, West, & Aiken, 2003).  Covariate-by-predictor interactions were entered 
as the product of the covariate of interest and the GABRA2 SNP. Before 
estimating the final models, a preliminary model was estimated to test covariate 
effects of age, SES, ethnicity, gender, and parental alcoholism. Those significant 
at p<.05 were retained. Then, a preliminary model was estimated to test the 
covariate by predictor interaction effects by entering them with all the covariates 
in a separate model because the large number of independent variables made it 
unfeasible to test all the covariates and covariate-by-predictor interactions in a 
single model. Interaction terms (along with their corresponding covariate terms, 
regardless of their significance levels) were retained at p<.05. 
RESULTS 
Descriptive Statistics and Correlations 
 Descriptive statistics for the first and second subsamples are displayed in 
Tables 3 and 4, respectively. All continuous and ordered categorical variables are 
coded such that high scores indicate high levels of the variable. In the first 
subsample note the low correlations between ADHD and substance use at all three 
waves, and the comparatively higher correlations between CD and substance use 
at all three waves (Table A1). Also note that across all waves, parental alcoholism 
is significantly correlated with ADHD symptoms, CD symptoms, and substance 
use experimentation (COAs reported more), age is significantly correlated with 
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substance experimentation (older adolescents more likely to use), and gender is 
significantly correlated with CD symptoms, such that males reported more CD 
symptoms than did females.  In the second subsample, note the significant 
correlation between the GABRA2 SNP (where AA is the reference group 
compared against the GG genotype) and substance use at wave 2 (Table B1). Also 
note the similar pattern of association compared to the first subsample with the 
covariates: age is significantly correlated with substance use at all waves, gender 
is significantly correlated with CD symptoms at wave 3, and parental alcoholism 
is significantly correlated with ADHD symptoms at all waves and CD symptoms 
at waves 1 and 2. Additionally at all waves, ADHD has comparatively lower 
correlations with substance experimentation than those between CD symptoms 
and substance experimentation, which is consistent with the current hypotheses. 
Surprisingly, parental alcoholism was not significantly correlated with the 
GABRA2 SNP despite the significant correlation between GABRA2 and 
substance experimentation at wave 2.  
Confirmatory Factor Analyses 
Confirmatory factor analyses were conducted using MPlus version 5.0 
(Muthén & Muthén, 1998-2007). Table 5 presents the fit indicators for each of the 
models evaluated. Both the one factor and two factor models did not fit the data 
adequately. For the one factor model, the model fit information follow: 
χ2=258.56, df=27, p<.001; RMSEA=0.169; CFI=0.704; WRMR=1.68. For the 
two factor model, χ2=194.176, df=26, p<.001; RMSEA=0.146; CFI=0.785; 
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WRMR=1.439. Thus, neither of these models met the cut-off values suggested by 
Hu & Bentler (1999) and Muthén & Muthén (2006) to indicate good model fit. 
However, the fit indices of the three-factor model suggested that this model 
provided a good fit to the data:  χ2=53.794, df= 24, p<.001; RMSEA=0.064; 
CFI=0.962; WRMR=0.684. Each indicator (CD, ADHD, and substance 
experimentation at each wave) loaded significantly onto their respective factors 
(p<.001).  
Despite the adequate model fit of the three-factor model, modification 
indices suggested that there was shared time-specific variance between the ADHD 
and CD indicators at the same wave. Indeed, both measures of ADHD and CD 
were derived from the same questionnaire. Thus, method and occasion-specific 
variance between these two indicators at each wave may explain the need for 
time-specific correlations to be modeled (Steyer, Ferring, & Schmitt, 1992). In the 
final three-factor model, this variance was modeled by allowing for the residuals 
of the ADHD and CD measures at the same time-points to be correlated. 
Correlations between the substance use and other indicators were not modeled.1 
Accounting for this method variance improved model fit indices, which are also 
presented below in Table 5: χ2=29.694, df=21, p=0.098; RMSEA=0.037; 
CFI=0.989; WRMR=0.684. Each indicator (CD, ADHD, and substance 
experimentation at each wave) loaded significantly onto their respective factors.  
Additionally, all three residual correlations were substantial and significant (See 
Figure 3). This three-factor model with correlated factors of ADHD, CD, and 
  
38 
 
substance use was used in all subsequent analyses. See Figure 3 for a pictorial 
summary of the model as well as the standardized factor loadings. 
Regression diagnostics 
Mplus does not yield regression diagnostics, thus the models were run in 
OLS Regression using SPSS to examine the potential influence of outliers on 
regression models. No abnormalities were detected and therefore no outliers were 
deleted from the subsequent analyses.  
Structural Equation Modeling: Covariate and Covariate-by-Predictor Interaction 
Effects 
 Preliminary analyses were conducted to determine which covariates and 
covariate-by-predictor interaction terms to include in the final analysis. Of note, 
all of the following analyses are done with the second subsample (N=138) who 
were genotyped. Different covariates for each latent outcome variable (ADHD, 
CD, and substance experimentation) were allowed because each of these 
outcomes may be differentially affected by the covariates and interactions. All 
continuous variables were centered. For each latent outcome variable, all of the 
covariates (age, gender, SES, ethnicity, and parent alcoholism) were tested as 
main effects. Parental alcoholism significantly predicted all three latent outcome 
variables, gender significantly predicted CD, and age significantly predicted 
substance use.  Covariate-by-predictor interactions were not included in the final 
models2. The final model retained parental alcoholism and gender as covariates 
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predicting CD, parental alcoholism predicting ADHD, and parental alcoholism 
and age predicting substance use.  
Structural Equation Modeling: Effect of GABRA2 
 The main effect of the GABRA2 SNP, rs279858, on each of the three 
latent outcome variables was tested using structural equation modeling.  A total of 
4, 3 and 4 independent variables were included in the models predicting CD, 
ADHD, and substance use, respectively. The factor loadings of each indicator on 
the three factors in this model (N=138) were similar to those from the previous 
model (N=302). See Figure 4. The model fit the data well: χ2= 49.836, df=55, 
p=0.67; RMSEA=0.00; CFI=1.00; WRMR=0.553. The results of these analyses 
are shown in Table 6. The beta regression coefficients reported below are 
unstandardized. Gender significantly predicted the CD latent factor (B=1.075, p 
=.016) such that boys were higher in CD. There was also a significant relation 
between parental alcoholism and CD (B=1.22, p =.003), such that COAs were 
higher in CD. The GABRA2 SNP did not have a significant main effect on CD: 
there were no significant differences between the AA and AG groups (B=-0.021, 
p=.964) or the AA and GG groups (B=-.247, p =.710). Parental alcoholism also 
significantly predicted the ADHD latent factor (B= 0.839, p =.003), such that 
COAs were higher on the ADHD factor. There were no significant differences 
between the AA and AG groups (B=-0.130, p =.661) or AA and GG groups (B=-
0.17, p =.714) on ADHD. Finally, both parental alcoholism and age were 
significant predictors of the substance experimentation factor, with COAs (B= 0. 
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592, p =.006) and older adolescents (B= 0.403, p =.001), reporting more 
substance experimentation. Interestingly, the GABRA2 SNP did have a main 
effect on the substance experimentation factor. The AA and AG groups (B= -0. 
431, p =.047) and AA and GG groups (B= -0. 774, p =.028) were significantly 
different on the substance experimentation factor. Those with the AA genotype 
reported significantly more substance experimentation compared to those with the 
AG or GG genotypes. Post-hoc analyses revealed no significant differences 
between the AG and GG genotypes (B= -0.367, p =.269). See Figure 4 for a 
pictorial summary of these results. In the final model, the predictors accounted for 
12.6% of the variance in the CD latent factor, 33.4% of the variance in the SE 
latent factor, and 8.7% of the variance in the ADHD latent factor.   The 
incremental contribution of the GABRA2 SNP over and above the other 
predictors was .18% for the CD factor, 9.5% for the SE factor, and .2% for the 
ADHD factor. 
DISCUSSION 
The first goal of the present study was to compare different factor models 
of youth externalizing behavior. Confirmatory factor analyses demonstrated that, 
out of a one-, two-, and three-factor model, the three-factor model fit the data 
best. In this model, each of the three correlated latent factors were represented by 
ADHD, CD, and SE indicators. The second goal of the study was to evaluate the 
influence of the GABRA2 SNP, rs279858, on externalizing behaviors. Structural 
equation modeling showed that this GABRA2 SNP had a significant main effect 
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on the SE factor over and above parental alcoholism and age, but did not have an 
effect on the ADHD or CD factors.  
 The results from confirmatory factor analyses are contrary to the initially 
hypothesized two-factor model, where CD and SE comprise one factor and 
ADHD comprises another. Although previous studies have provided support for 
the distinction between ADHD and CD in childhood (e.g. Nigg, 2003; Beauchaine 
et al., 2010) and have tested and supported a two-factor model where CD and 
substance use are distinct from ADHD in adulthood (e.g. Farmer et al., 2009), no 
modeling studies to date have tested this two-factor model in adolescence. 
Interestingly, taking into consideration the unique developmental issues 
experienced in adolescence can help us understand why the factor structure of 
externalizing disorders in adolescence may look different from that in adulthood. 
Adolescence is a stage characterized by experimental substance use (Petraitis, 
Flay, & Miller, 1995), and the severity of adolescent substance use often must be 
measured by the level and/or frequency of use rather than the categorical or 
dimensional scales of abuse or dependence that are used in adult studies (e.g. 
Young et al., 2000; Verona et al., 2011; Castellanos-Ryan et al., 2011). Although 
adolescent substance experimentation is a risk factor for future substance abuse 
and dependence (Chassin, Pitts, & Prost, 2002), not all adolescents who 
experiment with alcohol or drugs will go on to develop a substance use disorder. 
The common one-factor model of externalizing behaviors in adulthood may be 
reflective of a stronger common cause between substance use disorders and 
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conduct and antisocial behaviors than between substance experimentation and 
conduct problems. Thus, in adolescence substance experimentation may represent 
a meaningfully distinct, but correlated, factor with CD and ADHD that describes a 
subset of adolescents who experiment with alcohol and drugs but may not 
necessarily develop a substance-use disorder later in life. It is likely that CD and 
ADHD symptoms overlap with substance experimentation in adolescence, which 
is explained in our data by the significant correlations between the three factors, 
but there may be some distinct underlying processes that drive experimentation 
with substances and not externalizing symptomatology. Accordingly, two recent 
adolescent modeling studies used measures of substance use frequency and both 
found that substance use formed a factor that was distinct from CD and/or ADHD 
(Verona et al., 2011; Castellanos-Ryan et al., 2011). Further research specifically 
examining the differentiation between substance experimentation in adolescence 
and substance use disorder in adulthood may be helpful in gaining a better 
understanding of why the factor structure of externalizing disorders varies across 
development. Moreover, our results are not consistent with the one-factor model 
found in adult data (Kendler et al., 2003; Hicks et al., 2004; Vollebergh et al., 
2001). 
Although our results are not consistent with the previous literature that 
found evidence for one- and two- factor models, our findings are not inconsistent 
with the common notion that both general and specific etiologic factors exist 
within the externalizing disorders. For example, Krueger et al. (2002) found that a 
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single hierarchical externalizing factor characterized the co-occurrence among 
alcohol dependence, drug dependence, conduct disorder, antisocial behavior, and 
a disinhibitory personality style. However, after accounting for this single factor 
there were still specific etiological factors attributable to each syndrome.  
Furthermore, recent studies modeling adolescent psychopathology found that CD 
and substance use shared some common variance but also shared specific sources 
of variance (Castellanos-Ryan & Conrod, 2011; Verona et al., 2011). Researchers 
have also suggested that ADHD and CD share a common diathesis but may be 
distinguished by parenting influences (see Beauchaine et al., 2010) and that 
ADHD and CD both result from reactive and executive disinhibition processes, 
but that ADHD primarily results from executive disinhibitory deficits while CD 
primarily results from reactive disinhibitory deficits (Nigg, 2003). These studies 
show that similarities exist among these disorders but that each disorder is also 
influenced by unique processes. Indeed, while three separate factors had the best 
fit to our data, there were also substantial intercorrelations between ADHD, CD, 
and SE in the final model.  Thus, the findings from our competing alternate 
models of externalizing psychopathology in adolescence suggest that ADHD, CD, 
and SE have unique sources of significant specific sources variance but also may 
share common variance. However this study did not model a hierarchical single 
externalizing factor because, theoretically, modeling a higher order factor would 
not provide any additional information and would fit the same as our model with 
three correlated factors. Even though we did not model a higher order factor, the 
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significant and substantial correlations between the three factors provides 
evidence that they share common variance.   
 Our original hypothesis that the GABRA2 SNP, rs279858, would 
significantly predict the social norm violation disorders (CD and SE) and would 
not significantly predict the ADHD factor was not supported. Using the three 
latent factors from our best-fitting model as outcome variables, we found that 
GABRA2 significantly predicted the SE factor, but not the CD and ADHD 
factors. Specifically, we found that A allele homozygotes were more likely to 
experiment with substances (alcohol and other illicit drugs) than those with the 
A/G or G/G genotypes after controlling for adolescent age and parental 
alcoholism. A/G and G/G carriers did not differ in their substance 
experimentation.  
 Previous studies have identified two GABRA2 haplotype blocks in 
Caucasians, American Indians, and Asians, with significant association signals 
with alcoholism detected within the haplotype block extending downstream from 
intron 3 (Enoch et al., 2008). Numerous studies have found two major yin-yang 
haplotypes within this block, both of which account for a vast majority of the 
haplotype diversity in Caucasian and Asian samples. The haplotype tagged by the 
A allele of rs279858 is found to be of slightly higher frequency (‘major’ 
haplotype) than the haplotype tagged by the G allele of rs279858 (‘minor’ 
haplotype). While many previous studies have found a relation between GABRA2 
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and substance use and dependence, not all are in agreement regarding which allele 
or haplotype confers risk for such disorders.   
 For example Agrawal et al. (2006) found that the major, or more 
abundant, haplotype was associated most strongly with alcoholics with co-
occurring drug dependence in a mostly Caucasian sample saturated for alcoholism 
(from the Collaborative Studies on Genetics of Alcoholism; COGA). From the 
same COGA sample, Dick et al. (2006b) also found that the major haplotype-
tagging allele, A, on SNP rs279871 was associated with elevated rates of drug 
dependence and conduct disorder in adolescents from control or alcoholic 
families.  Furthermore, Lind et al. (2008) found that GABRA2 SNPs tagging the 
major allele were associated with alcohol dependence symptoms and age at first 
alcohol symptom in an adult Australian population sample and, in a case-control 
study of German treatment-seeking alcoholics, Soyka et al. (2008) demonstrated 
that the major haplotype was associated with alcoholism.  
On the other hand, several other case-control studies found the less 
frequent “minor” haplotype to be significantly more frequent among U.S. 
Caucasian (Covault et al., 2004), Russian (Lappalainen et al., 2005), and German 
(Fehr et al., 2006) treatment-seeking alcoholics than among controls. 
Interestingly, Covault et al. (2004) found that this minor haplotype was most 
strongly associated with alcoholics who were not drug dependent. Furthermore, 
the minor haplotype-tagging G allele of rs279858 was related to decreased 
unpleasurable effects of alcohol (e.g. dizziness, ringing, nausea, stomach bloating) 
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in a group of social drinkers (Pierucci-Lagha et al., 2005). Bauer et al. (2007) 
found that this same allele was associated with a higher daily probability of 
drinking and heavy drinking in alcoholics from the Project MATCH study, and 
Villafuerte et al. (2011) found evidence that this allele, and its associated minor 
haplotype, was related to alcohol dependence symptoms and NEO-PI-R 
Impulsiveness scores.  
Although seemingly contradictory, the literature appears to indicate that 
both of the yin-yang haplotypes can increase the risk for substance use disorders. 
In support of this notion are findings from Enoch et al. (2006) who demonstrated 
that in a sample of Finnish male alcoholic criminal offenders and controls, those 
with high trait anxiety (as measured by harm avoidance) and alcoholism had the 
highest frequency of the major haplotype, those with low trait anxiety and 
alcoholism had the highest frequency of the minor haplotype, and non-alcoholics 
(whose mean levels of trait anxiety were intermediate between the two alcohol 
groups) had intermediate frequencies of the major and minor haplotypes. Thus, 
both major and minor haplotypes were over-represented in alcoholics in this 
study. The authors propose that trait anxiety may play a role in explaining some 
of the discrepancies in the identification of a risk haplotype or allele in the 
GABRA2 gene. Namely, Enoch and colleagues hypothesize that studies where the 
minor haplotype was associated with increased risk for alcoholism may have 
sampled alcoholics who had lower trait anxiety, while those where the major 
haplotype was associated with risk may have studied alcoholics who had higher 
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trait anxiety. The failure to account for these variables may help explain some of 
the variability in the literature. 
Interestingly, Haughey et al., (2008) also found that both major and minor 
alleles of the rs279858 SNP conferred risk for an endophenotype of alcoholism. 
They found that those with the major haplotype-associated AA and minor 
haplotype-associated GG genotypes of SNP rs279858 reported greater alcohol-
induced positive mood and feelings of vigor after an alcohol infusion challenge as 
compared to AG heterozygotes. These findings are consistent with the notion that 
greater frequencies of both the major and minor alleles can increase the risk for 
alcoholism. Based on the findings from Enoch et al. (2006), it would be 
interesting to test whether the association between GABRA2 and substance use 
disorders is moderated by measures of anxiety and whether this could elucidate 
the nature of the risk conferring alleles in the GABRA2 gene. 
The lack of association between GABRA2 and ADHD is consistent with 
the original hypotheses and consistent with the current status of the literature. 
Indeed, to our knowledge this is the first study to examine the relationship 
between the GABRA2 gene and ADHD. Contrary to one of our initial hypotheses, 
the GABRA2 SNP was not associated with conduct disorder. These hypotheses 
were based on a study by Dick et al. (2006) who established a relation between 
self-reported CD and GABRA2 in children of treatment-seeking alcoholics and 
controls. Our results are consistent with a more recent replication study of 13-18 
year old adolescent patients from a university substance abuse treatment program 
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and controls, which did not find evidence for an association between the 
GABRA2 rs279871 SNP and self-reported CD in both case-control and family-
based association tests (Sakai et al., 2010).  
However, the lack of association between CD and GABRA2 in both our 
study and the study by Sakai and colleagues can potentially be explained by 
findings from Dick et al. (2007) who outlined the importance of environmental 
and developmental influences in studies of genetic association. In this study, 
growth mixture modeling was used to identify trajectories of externalizing 
behavior characterized by self-reports of aggression and delinquency in 
adolescents/young adults from 12-22 years and to examine the effect of SNPS in 
the GABRA2 gene and of parental monitoring on these externalizing behaviors. 
They revealed two classes of externalizing behaviors, one characterized by 
elevated and persistent behaviors into adulthood (elevated persistent) and the 
other characterized by a decrease in behavior from adolescence to adulthood 
(developmentally limited). They found that multiple SNPs in the GABRA2 gene 
had a main effect on class membership, with each additional copy of the major 
allele (e.g. SNPs rs279858, rs279871), that tag the major haplotype, increasing the 
odds of membership in the elevated persistent externalizing trajectory. Moreover, 
although no main effect of parental monitoring was present, parental monitoring 
moderated the effect of GABRA2 such that GABRA2 had a stronger influence on 
externalizing class membership under conditions of low monitoring compared to 
conditions of high monitoring. Thus, these findings highlight the need to consider 
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environmental influences, such as parental monitoring, in studies of genetic 
association. It might be that in our data, the presence of interactive environmental 
effects (e.g. parental monitoring) precluded the detection of a significant main 
effect of GABRA2 on CD.   Indeed, an important avenue for future research 
includes examining the effect of environmental factors in order to gain a better 
understanding of how genes affect behavior. Moreover, these results underscore 
the importance of considering developmental trajectories of problem behavior and 
highlight the possibility that GABRA2 actually plays a larger role in influencing 
pathways of problem behavior rather than behaviors observed at single time 
points. Although we did use three different time points to define the CD factor, 
this method does not capture the pattern and course of problem behaviors over 
time. While it is important to consider environmental and developmental factors, 
our study also differed methodologically from the study by Dick et al. (2006) 
because they used child-reported DSM-III-R CD diagnoses whereas we used 
child-reported Achenbach symptom scales of CD. The discrete versus categorical 
approach to classifying problem behaviors may well explain the discrepancies in 
our results as well. Finally, our DSM-oriented symptom scale of CD was missing 
three out of fifteen items (i.e. lacks guilt, breaks rules, sets fires). It could be that 
the accuracy of our CD measure was compromised due to missing these items. 
One unanticipated finding from our study was the non-significant 
correlation between parental alcoholism and GABRA2. This is especially 
surprising because there was a significant relation between GABRA2 and 
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adolescent substance experimentation. However, given that our measure of 
substance experimentation included both alcohol and illicit drugs, and given that 
some studies have shown the major haplotype of GABRA2 to have the strongest 
association with co-occurring alcohol and drug dependence (Agrawal et al., 
2006), it might be that GABRA2 would be significantly correlated with a measure 
of parental alcoholism and co-occurring drug dependence. Another interesting 
possibility to explain this finding is that parent trait anxiety may play a 
moderating role in the relation between parental alcoholism and GABRA2. 
Similarly, we were surprised that gender was not a significant predictor of the 
ADHD factor because prevalence rates consistently show that ADHD is more 
common in males than in females (Faraone et al., 2003). A potential explanation 
for the lack of gender differences in ADHD symptomatology is that youth self-
report was utilized. Perhaps if parent- or teacher-reported ADHD measures were 
used we would have seen this difference. This finding could also be due to the 
fact that our DSM-oriented ADHD scale was missing three of the seven items that 
comprise the scale (i.e. fails to finish, talks too much, loud). Perhaps these items 
discriminate between boys and girls’ self-reports of ADHD.  
Strengths, Limitations, and Future Directions 
 This study extends the literature on the unique and shared liabilities to 
externalizing disorders by investigating these phenomena in adolescents and by 
demonstrating that specific etiological differences in substance experimentation 
can be explained, in part, by genetic influences. Indeed, this study is one of few to 
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examine multiple competing factor structures of externalizing disorders in 
adolescents while also including substance use measures (Verona et al., 2011). 
This study also adds to the currently limited research on the influence of 
measured genetics on adolescent substance use. Furthermore, latent measures of 
CD, ADHD, and SE symptomatology were constructed in this study by using 
indicators of each disorder at three waves. Thus, our externalizing behavior 
outcomes represent somewhat of a trait-like measurement, which implies that we 
captured externalizing behaviors that were more stable across adolescence rather 
than limited to one specific stage of adolescence (e.g. pre-adolescence).  
 Although the current study contributes to the literature on the structure of 
adolescent externalizing disorders and the genetics of substance use, there are also 
limitations that should be considered as avenues for future research. Because the 
ADHD and CD items were taken from an older version of the Achenbach CBCL, 
we were not able to construct complete DSM-oriented scales. The ADHD scale 
was missing three out of seven items and the CD scale was missing three out of 
fifteen items. Thus, although the internal consistency for each scale was still 
good, this could mean that our definitions of ADHD and CD were not as accurate 
as possible. Additionally because single-reporter models may lead to bias, a 
limitation of our study was that we only utilized adolescent self-reports of ADHD, 
CD, and SE. In the future, multiple-reporter models should be examined to see if 
the same factor structure and relations hold.  
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 It is important to consider that these analyses used a single SNP to predict 
adolescent outcomes. In future analyses it will be important to utilize more robust 
genetic measures such as estimating haplotypes or diplotypes of the GABRA2 
gene. As single-gene associations are often of small effect size, it will also be 
important to investigate how environmental factors influence the relation between 
genes and adolescent externalizing behaviors. For example, interactions between 
parental monitoring and GABRA2 might yield significant effects on adolescent 
CD in our sample (Dick et al., 2007). Similarly, examining the effect of gene-by-
gene interactions may lead to a better understanding of the biological mechanisms 
that influence externalizing behaviors.    
 Another important question that stems from these analyses concerns the 
mechanisms through which GABRA2 influences substance experimentation in 
adolescence. Indeed, understanding how GABRA2 influences substance use may 
give us greater insight into the functional role of the gene. Interestingly, multiple 
facets of disinhibition may differentiate between externalizing disorders and 
GABRA2 has also been hypothesized to affect SUDs through disinhibitory 
processes. It would be interesting to investigate whether certain facets of 
disinhibition mediate the relation between GABRA2 and SE.  Finally, this study 
awaits replication with broader samples including those with more diverse ethnic 
groups. 
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Summary and Conclusions 
In conclusion, this study confirmed findings from previous research 
demonstrating that ADHD, CD, and SE each have unique sources of significant 
unique sources of variance. Due to the significant intercorrelations between the 
three problem behaviors, this study also partially supports the notion of a broader 
externalizing factor that accounts for commonalities among externalizing 
disorders. However, this conclusion should be viewed with caution because we 
did not actually model a hierarchical externalizing factor due to sample size 
limitations. Our study also extends previous research by showing that biological 
mechanisms act as a unique etiological factor in the development of substance 
experimentation in adolescence. Specifically, possession of the homozygous 
major allele genotype of the GABRA2 SNP, rs279858, may be one unique risk 
factor for substance use experimentation in adolescence.  
  
Table 1. 
Comparing First Subsample to Excluded Participants  
*statistical significance. a 4 items (CBCL), 0-8. b12 items (CBCL), 0-24. c9 substance use items 
truncated: ordinal categorical variable, range: 0-2. d1 (grade school), 2 (some high school (HS)), 3 
(HS graduate), 4 (technical school), 5 (some college), 6 (college graduate), and 7 (graduate 
school/professional school).  enot used in final analyses, used for comparing between groups. 
 Included Excluded   
Covariates, Outcome 
Variables 
N Mean (SD) N Mean (SD) t p-value 
G2 Age       
       Wave 1 302 13.80(1.03) 152 12.07(1.45) -13.112 <.001* 
       Wave 2 302 14.74(1.03) 147 13.00(1.46) -12.936 <.001* 
       Wave 3 302 15.74(1.04) 143 13.95(1.44) -13.289 <.001* 
G2 report of own ADHDa       
       Wave 1 302 3.96(1.90) 150 3.54(1.93) -2.207 .028* 
       Wave 2 302 3.67(1.83) 146 3.51(1.91) -.850 .396 
       Wave 3 302 3.71(1.89) 141 3.52(1.88) -.956 .339 
G2 report of own CDb       
       Wave 1 302 3.34(3.12) 147 2.32(3.00) -3.292 .001* 
       Wave 2 302 3.60(3.16) 144 2.50(2.78) -3.570 <.001* 
       Wave 3 302 4.05(3.36) 132 3.13(3.44) -2.600 .010* 
G2 report of own substance 
experimentationc 
      
       Wave 1 302 0.22(0.55) 152 0.19(0.55) -.570 .569 
       Wave 2 302 0.35(0.67) 147 0.27(0.63) -1.266 .207 
       Wave 3 302 0.44(0.72) 143 0.28(0.64) -2.419 .016* 
Covariates N % N % Chi-
Square 
p- 
value 
G2 COA Status 
                   Non-COA=0 
                   COA=1 
     
302 47.4% non-
COA 
52.6% 
COA 
152 42.8% non-
COA 
57.2% 
COA 
.857 .355 
G1 SES (highest-reported 
education)d 
                   
302 Mean=4.86 147 Mean=4.88 .778 .993 
G2 Gender 
                  0=Female 
                  1=Male 
302 47.0% 
Female 
53.0% Male 
152 47.4% 
Female 
52.6% Male 
.005 .944 
G2 Ethnicity 
                  0=Non-Hispanic 
Caucasian 
                  1=Hispanic 
                  2= Other Ethnicity e 
302 73.5% 
Caucasian 
26.5% 
Hispanic 
147 68% 
Caucasian 
17.0% 
Hispanic 
15% Other 
49.41 <001* 
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Table 2. 
Comparing Second Subsample to Excluded Participants 
*statistical significance. a4 items (CBCL), 0-8. b12 items (CBCL), 0-24. c 9 substance use items 
truncated to form an ordinal categorical variable ranging from 0-2. d1 (grade school), 2 (some high 
school), 3 (high school graduate), 4 (technical school), 5 (some college), 6 (college graduate), and 
7 (graduate school/professional school).  eThis code was not used in the final analyses, but was 
just used for the purposes of comparing between groups. 
 Included Excluded   
Covariates, Outcome 
Variables 
N Mean (SD) N Mean (SD) t p-value 
G2 Age       
       Wave 1 138 13.77(1.04) 316 12.98(1.52) -6.355 <.001* 
       Wave 2 138 14.70(1.05) 311 13.93(1.53) -6.178 <.001* 
       Wave 3 138 15.70(1.06) 307 14.92(1.53) -6.243 <.001* 
G2 report of own ADHDa 138      
       Wave 1 138 3.83(1.97) 314 3.82(1.89) -.092 .927 
       Wave 2 138 3.62(1.85) 310 3.61(1.86) -.016 .987 
       Wave 3 138 3.59(1.84) 305 3.68(1.91) .420 .675 
G2 report of own CDb 138      
       Wave 1 138 2.67(2.85) 311 3.15(3.22) 1.508 .132 
       Wave 2 138 3.27(3.05) 308 3.23(3.10) -.109 .913 
       Wave 3 138 3.70(3.23) 296 3.80(3.49) .269 .788 
G2 report of own substance 
experimentationc 
138      
       Wave 1 138 .17(.48) 316 .23(.57) 1.240 .216 
       Wave 2 138 .33(.68) 311 .32(.66) -.269 .788 
       Wave 3 138 .40(.68) 307 .39(.71) -.153 .879 
Covariates N % N % Chi-
Square 
p- 
value 
G2 COA Status 
                   Non-COA=0 
                   COA=1 
     
138 47.1% non-
COA 
52.9% 
COA 
316 45.3% non-
COA 
54.7% 
COA 
.132 .716 
G1 SES (highest-reported 
education)d 
138 Mean=4.78 147 Mean=4.73 2.779 .836 
G2 Gender 
                  0=Female 
                  1=Male 
138 50.7% 
Female 
49.3% Male 
316 45.6% 
Female 
54.3% Male 
1.024 .311 
G2 Ethnicity 
                  0=Non-Hispanic 
Caucasian 
                  1=Hispanic 
                  2= Other       
Ethnicity e 
138 72.5% 
Caucasian 
27.5% 
Hispanic 
311 71.4% 
Caucasian 
21.5% 
Hispanic 
7.1% Other 
11.246 .024* 
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Table 3.  
Descriptive Statistics for First Subsample. 
Note. All continuous variables are coded such that high scores indicate high levels of the variable.  
aConsists of four items from the CBCL, scores range from 0-8. bConsists of twelve items from the 
CBCL, scores range from 0-24. cConsists of nine substance use items that were truncated to form 
an ordinal categorical variable ranging from 0-2.d0=Female, 1=Male. e1=Caucasian, 2=Hispanic, 
3=Other Ethnicity. f0=non-COA, 1=COA. g1 (grade school), 2 (some high school), 3 (high school 
graduate), 4 (technical school), 5 (some college), 6 (college graduate), and 7 (graduate 
school/professional school).   
 N Min. Max. Mean(SD) Skewness(SE) Kurtosis (SE) 
G2 Age       
       Wave 1 302 12.00 16.61 13.80(1.03) .24(.14) -.71(.28) 
       Wave 2 302 12.90 17.60 14.74(1.03) .24(.14) -.69(.28) 
       Wave 3 302 13.84 18.63 15.74(1.04) .21(.14) -.67(.28) 
G2 SES g 302 1.00 7.00 4.768(1.49) -.53(.14) -.28(.28) 
G2 report of own 
ADHDa 
      
       Wave 1 302 .00 8.00 3.960(1.90) .02(.14) -.45(.28) 
       Wave 2 302 .00 8.00 3.67(1.83) -.06(.14) -.36(.28) 
       Wave 3 302 .00 8.00 3.71(1.89) .09(.14) -.29(.28) 
G2 report of own CDb       
       Wave 1 302 .00 17.00 3.34(3.12) 1.17(.14) 1.40(.28) 
       Wave 2 302 .00 17.00 3.60(3.16) 1.29(.14) 2.01(.28) 
       Wave 3 302 .00 16.00 4.05(3.36) 1.05(.14) .77(.28) 
G2 report of own 
substance 
experimentationc 
     
 
       Wave 1 302 .00 2.00 .22(.55) 2.40(.14) 4.57(.28) 
       Wave 2 302 .00 2.00 .35(.67) 1.69(.14) 1.31(.28) 
       Wave 3 302 .00 2.00 .44(.72) 1.29(.14) .16(.28) 
 N %     
G2 Genderd 302 47.0% (N=142) Female 
G2 Ethnicitye 302 73.5% (N=222) Non-Hispanic Caucasian 
G2 COA Statusf 302 52.6% (N=159) COA 
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Table 4.  
Descriptive Statistics for Second Subsample. 
Note. All continuous variables coded so high scores are high levels of variable.  a4 items (CBCL), 
0-8. b12 items (CBCL), 0-24. c9 substance use items to form ordinal categorical variable, 0-
2.d0=Female, 1=Male. e1=Caucasian, 2=Hispanic, 3=Other Ethnicity. f0=non-COA, 1=COA. g1 
(grade school), 2 (some high school), 3 (high school graduate), 4 (technical school), 5 (some 
college), 6 (college graduate), and 7 (graduate school/professional school).
 N Min. Max. Mean(SD) Skewness (SE) 
Kurtosis 
(SE) 
G2 Age       
       Wave 1 138 12.00 15.89 13.77(1.04) .16(.21) -.93 (.41) 
       Wave 2 138 12.96 16.84 14.70(1.05) .14(.21) -.92(.41) 
       Wave 3 138 13.89 17.86 15.70(1.06) .12(.21) -.90(.41) 
G2 SES g 138 1.00 7.00 4.78(1.48) -.56(.21) -.13(.41) 
G2 report of own 
ADHDa       
       Wave 1 138 .00 8.00 3.83(1.97) -.03(.21) -.58(.41) 
       Wave 2 138 .00 8.00 3.62(1.85) -.14(.21) -.46(.41) 
       Wave 3 138 .00 8.00 3.59(1.84) .04(.21) -.05(.41) 
G2 report of own 
CDb       
       Wave 1 138 .00 17.00 2.67(2.85) 1.70(.21) 4.07(.41) 
       Wave 2 138 .00 16.00 3.27(3.05) 1.35(.21) 2.28(.41) 
       Wave 3 138 .00 16.00 3.70(3.23) 1.25(.21) 1.57(.41) 
G2 report of own 
substance 
experimentationc 
      
       Wave 1 138 .00 2.00 .17(.48) 2.92(.21) 7.72(.41) 
       Wave 2 138 .00 2.00 .33(.68) 1.78(.21) 1.58(.41) 
       Wave 3 138 .00 2.00 .40(.68) 1.44(.21) .69(.41) 
 N %     
G2 Genderd 138 50.7% (N=70) Female 
G2 GABRA2 rs279858 138 67.4% (N=93) AA/AG genotype; 32.6% (N=45) AA genotype 
G2 Ethnicitye 138 72.5% (N=100) Non-Hispanic Caucasian 
G2 COA Statusf 138 52.9% (N=73) COA 
  
Figure 1.  
Competing Confirmatory Factor Analytic Models with First Subsample 
One-Factor and Two-Factor Models of Externalizing Disorders 
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*Note. ADHD: Attention-Deficit Hyperactivity Disorder. CD: Conduct Disorder.  
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Figure 2. 
Competing Confirmatory Factor Analytic Models with First Subsample:  
Three-Factor Model of Externalizing Disorders 
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*Note. ADHD: Attention-Deficit Hyperactivity Disorder. CD: Conduct Disorder. Subs: Substance 
Experimentation. 
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Table 5.  
Model Fit Indices for One-, Two-, and Three-Factor Models of Externalizing 
Behaviors in First Subsample. 
 
 
Indicators of Model Fit 
 χ2    
Model Value df p value CFI RMSEA WRMR 
One-Factor 258.555 27 <.0001 0.704 0.169 1.683 
Two-Factor 194.176 36 <.0001 0.785 0.146 1.439 
Three-
Factor 
53.794 24 0.0005 0.962 0.064 0.684 
Three-
Factor with 
time-
specific 
correlations 
29.694 21 0.0983 0.989 0.037 0.499 
 
 
  
Figure 3.  
Path Diagram for Three-Factor Model with time-specific correlations: First Subsample 
6
1
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Note. Standardized parameter estimates and standard errors in parentheses are presented here.  *p < .001. ap=.032. ADHD: Attention-Deficit Hyperactivity 
Disorder. CD: Conduct Disorder.  
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Table 6. 
GABRA2 SNP rs279858 and Covariates Predicting Latent Factors of Three-Factor Model: ADHD, CD, and Substance Use in Second 
Subsample 
 
 
 ADHD CD Substance Experimentation 
Predictor B SE B β p  B SE B β p  B SE B β p  
rs279858  
DC1 
-0.130 0.296    -0.046 0.66
1 
-0.021 0.462   -
0.005 
0.964 -0. 431*   0.21
8      
-0.229 0.047 
rs279858 
DC2 
-0.17 0.465    -0.043 0.71
4 
-.247 0.663   -
0.040 
0.710 -0. 774* 0.35
2      
-0.295 0.028 
Age -- -- -- -- -- -- -- -- 0.403**    0.12
4      
0.451 0.001 
COA 0.839**   0.286    0.294 0.00
3 
1.22**     0.409   0.277 0.003 0. 
592**      
0.21
5       
0.314 0.006 
Gender -- -- -- -- 1.075*     0.445   0.244 0.016 -- -- -- -- 
 
 
 
 
6
2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
**p<.01 *p<.05. ADHD: Attention Deficit Hyperactivity Disorder. CD: Conduct Disorder. DC1= dummy code of GABRA2 genotype (AG=1, AA=reference 
group) DC2= dummy code of GABRA2 genotype (GG=1, AA=reference group). Gender: 0=Female, 1=Male. COA: 0=non-COA, 1=COA. Higher levels of age 
represent older age.  As each factor was allowed to have unique covariates, the ‘- -‘ are covariates that were not included in the prediction of each latent factor.
 
  
Figure 4.  
Predicting Latent Factors ADHD, CD, and Substance Use from GABRA2 with Second Subsample 
 
0.633**
0.559**
-0. 774*
-0 247
-0 170
-0.431*
-0 021
-0 130
rs279858 DC1 
W1 CD 
W2 CD 
W1 
Substance 
W2 
Substance 
W3 
Substance 
W1 
ADHD 
W2 
ADHD
ADHD
CD
Substance 
experimentation
rs279858 DC2 
 
6
3
 
R1 
W3 CD 
W3 
ADHD
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0.842**
0.727**
0.747**0.772**
0.876**0.829** 
0.938**
0.723**
R2 
R3 
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Note. Bold font indicates statistical significance. *p<.05, p<.001**. The covariates were not included in this model for ease of presentation. See Table 8 for the effect of 
covariates on the three latent factors.  For correlations among the exogenous variables (DC1, DC2, gender, parent alcoholism, and age) refer to Table B1. Three factor model is not 
wholly depicted for ease of presentation (e.g. time-specific correlations): See Figure 2.   Parameter estimates are standardized. DC1= dummy code of GABRA2 genotype (AG=1, 
AA=reference group) DC2= dummy code of GABRA2 genotype (GG=1, AA=reference group). ADHD: Attention-Deficit Hyperactivity Disorder. CD: Conduct Disorder. 
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These are items that describe people.  Please use them to describe the way that 
you have been during the past three months.  In the past three months, how often 
have much of these things been true of you? 
1. Easily distractible. 
2. Very true or often true 
1. Somewhat or sometimes true 
 0. Not true 
2. Fidgety, has difficulty sitting still. 
3. Runs away from home. 
4. Truant, skips school. 
5. Steals outside of the home, e.g. shoplifting. 
6. Mean or cruel to others. 
7. Destroys things belonging to others. 
8. Starts fights. 
9. Hangs around with kids who get in trouble. 
10. Acts without stopping to think. 
11. Lies or cheats. 
12. Physically attacks people. 
13. Steals things at home. 
14. Swearing or obscene language. 
15. Threatens people. 
16. Can’t concentrate. 
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These questions are about alcohol and drug use. When we ask you about drug use 
we do NOT mean medicines that were given to you by your doctor. We want to 
know about your use of drugs that were NOT PRESCRIBED BY YOUR 
DOCTOR. 
1. In the past year, how many times have you gotten drunk on alcohol? (not just 
light-headed) 
 0. Never 
 1. 1-2 times in my life 
 2. 3-5 times in my life 
 3. More than 5 times, but less than once a month 
 4. 1-3 times a month 
 5. 1-2 times a week 
 6. 3-5 times a week 
 7. Every day. 
2. In the past year, how many times did you use marijuana (grass, pot) or hashish 
(hash, hash oil)? 
3. In the past year, how many times did you use amphetamines (uppers, speed, 
meth, dex, pep pills, ice)? 
4. In the past year, how many times did you use quaaludes (quads, sopers, 
methaqualone) or barbituates (downs, downers)? 
5. In the past year, how many times did you use tranquilizers (valium, librium)? 
 81 
 
6. In the past year, how many times did you use hallucinogens (LSD, PCP, 
ANGEL DUST, MESCALINE, PSILOCYBIN, PEYOTE, DMT, 
MUSHROOMS, SHROOMS)? 
7. In the past year, how many times did you use cocaine (coke) or crack? 
8. In the past year, how many times did you use opiate drugs (These include 
codeine, demerol, morphine, darvon, opium, percodan, percocet, and heroin 
(horse, skag, smack))? 
9. In the past year, how many times did you use inhalant drugs? 
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APPENDIX C 
TABLES REPORTING CORRELATIONS FOR FIRST SUBSAMPLE 
  
Table C1.  
Correlations Between Covariates and Indicators of Latent Factors for First 
Subsample 
 G2 
Age
d 
G2 
Gender 
b 
G2 
COA 
c 
G2 
SES 
G2 
Ethnicity 
a 
G2 
ADHD 
Wave 1 
G2 
ADHD 
Wave 2 
Pearson 
Correlation 
1 -.010 -.089 .026 .086 .066 .114* 
Sig. (2-
tailed)   
.857 .125 .650 .136 .254 .048 
G2 
Aged 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
-
.010 
1 .037 .103 -.066 .015 -.056 
Sig. (2-
tailed) 
.857   .525 .073 .253 .791 .329 
G2 
Gender 
b 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
-
.089 
.037 1 -.130* .133* .124* .212** 
Sig. (2-
tailed) 
.125 .525   .023 .020 .032 .000 
G2 
COA 
Status c 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.026 .103 -.130* 1 -.291** -.052 -.040 
Sig. (2-
tailed) 
.650 .073 .023   .000 .371 .492 
G2 
SES 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.086 -.066 .133* -
.291** 
1 .009 .020 
Sig. (2-
tailed) 
.136 .253 .020 .000   .881 .735 
G2 
Ethnici
ty a 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.066 .015 .124* -
.052 
.009 1 .557** 
Sig. (2-
tailed) 
.254 .791 .032 .371 .881   .000 
G2 
ADHD 
Wave 
1 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.114* -.056 .212** -
.040 
.020 .557** 1 
Sig. (2-
tailed) 
.048 .329 .000 .492 .735 .000   
G2 
ADHD 
Wave 
2 
N 302 302 302 302 302 302 302 
 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. 
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability.  
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Table C2.  
Correlations Between Covariates and Indicators of Latent Factors for First 
Subsample (cont.) 
 G2 
ADHD 
W3 
G2 
CD 
W1 
G2 
CD 
W2 
G2 
CD 
W3 
G2 
Subs. 
W1e 
G2 
Subs. 
W2e 
G2 
Subs. 
W3e 
Pearson 
Correlation 
.081 .126* .054 .026 .284** .216** .198** 
Sig. (2-
tailed) 
.158 .029 .352 .652 .000 .000 .001 
G2 
Aged 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.013 .116* .141* .247** -.055 -.016 .000 
Sig. (2-
tailed) 
.825 .044 .014 .000 .344 .781 .999 
G2 
Gender 
b 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.114* .148** .222** .185** .167** .165** .208** 
Sig. (2-
tailed) 
.048 .010 .000 .001 .004 .004 .000 
G2 
COA 
Status c 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
-.014 -.090 -.102 -.047 -.006 .031 -.022 
Sig. (2-
tailed) 
.815 .117 .076 .414 .917 .591 .708 
G2 
SES 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
-.003 .084 .067 .061 .072 .013 .026 
Sig. (2-
tailed) 
.962 .148 .247 .290 .211 .819 .649 
G2 
Ethnici
ty a 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.473** .507** .356** .327** .114* .151** .187** 
Sig. (2-
tailed) 
.000 .000 .000 .000 .047 .008 .001 
G2 
ADHD 
Wave 
1 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.546** .364** .476** .325** .168** .276** .256** 
Sig. (2-
tailed) 
.000 .000 .000 .000 .003 .000 .000 
G2 
ADHD 
Wave 
2 
N 302 302 302 302 302 302 302 
 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. 
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability. eSubs.=Substance Experimentation. 
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Table C3.  
Correlations Between Covariates and Indicators of Latent Factors for First 
Subsample (cont.) 
 
G2 
Aged 
G2 
Gender 
b 
G2 
COAc 
G2 
SES 
G2 
Ethnicity 
a 
G2 
ADHD 
W1 
G2 
ADHD 
W2 
Pearson 
Correlation 
.081 .013 .114* -
.014 
-.003 .473** .546**
Sig. (2-tailed) .158 .825 .048 .815 .962 .000 .000 
G2 
ADHD 
W3 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.126* .116* .148** -
.090 
.084 .507** .364**
Sig. (2-tailed) .029 .044 .010 .117 .148 .000 .000 
G2 CD 
W1 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.054 .141* .222** -
.102 
.067 .356** .476**
Sig. (2-tailed) .352 .014 .000 .076 .247 .000 .000 
G2 CD 
W2 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.026 .247** .185** -
.047 
.061 .327** .325**
Sig. (2-tailed) .652 .000 .001 .414 .290 .000 .000 
G2 CD 
W3 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.284** -.055 .167** -
.006 
.072 .114* .168**
Sig. (2-tailed) .000 .344 .004 .917 .211 .047 .003 
G2 
Subs. 
W1e 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.216** -.016 .165** .031 .013 .151** .276**
Sig. (2-tailed) .000 .781 .004 .591 .819 .008 .000 
G2 
Subs. 
W2e 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.198** .000 .208** -
.022 
.026 .187** .256**
Sig. (2-tailed) .001 .999 .000 .708 .649 .001 .000 
G2 
Subs. 
W3e 
N 302 302 302 302 302 302 302 
 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. 
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability. eSubs.=Substance Experimentation. 
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Table C4.  
Correlations Between Covariates and Indicators of Latent Factors for First 
Subsample (cont.) 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. 
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability. eSubs.=Substance Experimentation.
 G2 
ADHD 
W3 
G2 
CD 
W1 
G2 
CD 
W2 
G2 
CD 
W3 
G2 
Subs. 
W1e 
G2 
Subs. 
W2e 
G2 
Subs. 
W3e 
Pearson 
Correlation 
1 .329** .371** .473** .130* .127* .261** 
Sig. (2-
tailed)   
.000 .000 .000 .023 .027 .000 
G2 
ADHD 
Wave 3 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.329** 1 .609** .545** .342** .315** .373** 
Sig. (2-
tailed) 
.000   .000 .000 .000 .000 .000 
G2 CD 
Wave 1 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.371** .609** 1 .602** .265** .419** .379** 
Sig. (2-
tailed) 
.000 .000   .000 .000 .000 .000 
G2 CD 
Wave 2 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.473** .545** .602** 1 .163** .216** .403** 
Sig. (2-
tailed) 
.000 .000 .000   .005 .000 .000 
G2 CD 
Wave 3 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.130* .342** .265** .163** 1 .511** .417** 
Sig. (2-
tailed) 
.023 .000 .000 .005   .000 .000 
G2 
Subs. 
W1e 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.127* .315** .419** .216** .511** 1 .595** 
Sig. (2-
tailed) 
.027 .000 .000 .000 .000   .000 
G2 
Subs. 
W2e 
N 302 302 302 302 302 302 302 
Pearson 
Correlation 
.261** .373** .379** .403** .417** .595** 1 
Sig. (2-
tailed) 
.000 .000 .000 .000 .000 .000   
G2 
Subs. 
W3e 
N 302 302 302 302 302 302 302 
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TABLES REPORTING CORRELATIONS FOR SECOND SUBSAMPLE 
 
  
Table D1. Correlations Between Covariates and Indicators of Latent Factors for 
Second Subsample.  
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels of the variable. 
a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. c0=non-COA, 1=COA. dG2 Age is 
age at wave 3 because there was increased variability. e0=AA genotype, reference group 1=AG 
genotype. f0=AA genotype, reference group, 1=GG genotype.
 AG 
group 
e 
GG 
group 
f 
G2 
Age
d 
G2 
Gender 
b 
G2 
COA 
c 
G2 
SES 
G2 
Ethnic a 
G2 
ADHD 
W1 
Pearson 
Correlation 
1 -
.442** 
.053 .044 -.003 .026 .006 -.030 
Sig. (2-
tailed)   
.000 .538 .607 .977 .762 .948 .731 
AG 
group e 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-
.442** 
1 -
.051 
-.095 .076 -
.061 
-.035 .015 
Sig. (2-
tailed) 
.000   .551 .269 .373 .481 .681 .857 
GG 
group f 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.053 -.051 1 .076 -.128 -
.034 
.062 -.047 
Sig. (2-
tailed) 
.538 .551   .373 .133 .692 .467 .586 
G2 
Age 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.044 -.095 .076 1 -.086 .135 -.121 .010 
Sig. (2-
tailed) 
.607 .269 .373   .314 .114 .158 .909 
G2 
Gender 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-.003 .076 -
.128 
-.086 1 -
.099 
.127 .208* 
Sig. (2-
tailed) 
.977 .373 .133 .314   .246 .139 .014 
G2 
COA  
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.026 -.061 -
.034 
.135 -.099 1 -.359** -.067 
Sig. (2-
tailed) 
.762 .481 .692 .114 .246   .000 .432 
G2 
SES 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.006 -.035 .062 -.121 .127 -
.359
** 
1 .019 
Sig. (2-
tailed) 
.948 .681 .467 .158 .139 .000   .822 
G2 
Ethnic 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-.030 .015 -
.047 
.010 .208* -
.067 
.019 1 
Sig. (2-
tailed) 
.731 .857 .586 .909 .014 .432 .822   
G2 
ADHD 
W1 
N 138 138 138 138 138 138 138 138 
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Table D2. Correlations Between Covariates and Indicators of Latent Factors for 
Second Subsample (cont.) 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male.  
 G2 
ADHD 
W2 
G2 
ADHD 
W3 
G2 
CD 
W1 
G2 
CD 
W2 
G2 
CD 
W3 
G2 
Subs. 
W1e 
G2 
Subs. 
W2e 
G2 
Subs.
W3e 
Pearson 
Correlation 
-.018 .002 .099 -
.049 
.020 .000 -.086 -.058
Sig. (2-
tailed) 
.830 .984 .246 .567 .818 1.000 .315 .500
AG 
group e 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.012 -.049 -
.129 
-
.044 
.045 -.106 -.180* -.041
Sig. (2-
tailed) 
.892 .566 .132 .608 .597 .215 .035 .634
GG 
group f 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.046 .074 -
.005 
.021 .033 .202* .242** .269**
Sig. (2-
tailed) 
.595 .386 .951 .811 .704 .018 .004 .001
G2 
Age 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.025 .044 .113 .151 .289
** 
-.071 -.036 -.002
Sig. (2-
tailed) 
.775 .606 .187 .076 .001 .407 .676 .980
G2 
Gender 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.229** .179* .157 .250
** 
.166 .148 .144 .127
Sig. (2-
tailed) 
.007 .035 .066 .003 .052 .084 .093 .138
G2 
COA  
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
-.076 .088 -
.044 
-
.047 
.029 .031 .058 .021
Sig. (2-
tailed) 
.376 .306 .605 .586 .735 .719 .498 .803
G2 
SES 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
-.083 -.076 .076 .084 .037 .125 .032 .045
Sig. (2-
tailed) 
.334 .376 .373 .325 .668 .144 .709 .604
G2 
Ethnici
ty 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.572** .538** .459
** 
.336
** 
.357
** 
-.025 .086 .176*
Sig. (2-
tailed) 
.000 .000 .000 .000 .000 .774 .317 .039
G2 
ADHD 
W1 
N 138 138 138 138 138 138 138 138
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability. e0=AA genotype, reference group 1=AG genotype. f0=AA genotype, 
reference group, 1=GG genotype. eSubs.=Substance Experimentation. 
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Table D3.  
Correlations Between Covariates and Indicators of Latent Factors for Second 
Subsample (cont.) 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels of the variable. 
a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male. c0=non-COA, 1=COA. dG2 Age is 
age at wave 3 because there was increased variability. e0=AA genotype, reference group 1=AG 
genotype. f0=AA genotype, reference group, 1=GG genotype. 
 
AG 
group 
e 
GG 
group 
f 
G2 
Age
d 
G2 
Gender 
b 
G2 
COAc 
G2 
SES 
G2 
Ethnic a 
G2 
ADHD 
W1 
Pearson 
Correlation 
-.018 .012 .046 .025 .229** -
.076 
-.083 .572** 
Sig. (2-
tailed) 
.830 .892 .595 .775 .007 .376 .334 .000 
G2 
ADHD 
W2 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.002 -.049 .074 .044 .179* .088 -.076 .538** 
Sig. (2-
tailed) 
.984 .566 .386 .606 .035 .306 .376 .000 
G2 
ADHD 
W3 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.099 -.129 -
.005 
.113 .157 -
.044 
.076 .459** 
Sig. (2-
tailed) 
.246 .132 .951 .187 .066 .605 .373 .000 
G2 CD 
W1 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-.049 -.044 .021 .151 .250** -
.047 
.084 .336** 
Sig. (2-
tailed) 
.567 .608 .811 .076 .003 .586 .325 .000 
G2 CD 
W1 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.020 .045 .033 .289** .166 .029 .037 .357** 
Sig. (2-
tailed) 
.818 .597 .704 .001 .052 .735 .668 .000 
G2 CD 
W3 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
.000 -.106 .202
* 
-.071 .148 .031 .125 -.025 
Sig. (2-
tailed) 
1.000 .215 .018 .407 .084 .719 .144 .774 
G2 
Subs. 
W1 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-.086 -.180* .242
** 
-.036 .144 .058 .032 .086 
Sig. (2-
tailed) 
.315 .035 .004 .676 .093 .498 .709 .317 
G2 
Subs. 
W2 
N 138 138 138 138 138 138 138 138 
Pearson 
Correlation 
-.058 -.041 .269
** 
-.002 .127 .021 .045 .176* 
Sig. (2-
tailed) 
.500 .634 .001 .980 .138 .803 .604 .039 
G2 
Subs. 
W3 
N 138 138 138 138 138 138 138 138 
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Table D4.  
Correlations Between Covariates and Indicators of Latent Factors for Second 
Subsample (cont.) 
*p<.05, **p<.01. For all continuous variables, higher values indicate higher levels 
of the variable. a0=non-Hispanic Caucasian, 1=Hispanic.  b0=Female, 1=Male.  
 G2 
ADHD 
W2 
G2 
ADHD 
W 3 
G2 
CD 
W1 
G2 
CD 
W2 
G2 
CD 
W3 
G2 
Subs. 
W1e 
G2 
Subs. 
W2e 
G2 
Subs. 
W3e 
Pearson 
Correlation 
1 .535** .355*
* 
.466
** 
.271
** 
.114 .319** .228**
Sig. (2-tailed)   .000 .000 .000 .001 .181 .000 .007
G2 
ADHD 
W2 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.535** 1 .378*
* 
.345
** 
.469
** 
.094 .145 .207*
Sig. (2-tailed) .000   .000 .000 .000 .271 .090 .015
G2 
ADHD 
W3 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.355** .378** 1 .625
** 
.559
** 
.340** .295** .324**
Sig. (2-tailed) .000 .000   .000 .000 .000 .000 .000
G2 CD 
W1 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.466** .345** .625*
* 
1 .617
** 
.350** .437** .424**
Sig. (2-tailed) .000 .000 .000   .000 .000 .000 .000
G2 CD 
W1 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.271** .469** .559*
* 
.617
** 
1 .179* .169* .368**
Sig. (2-tailed) .001 .000 .000 .000   .035 .047 .000
G2 CD 
W3 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.114 .094 .340*
* 
.350
** 
.179
* 
1 .573** .492**
Sig. (2-tailed) .181 .271 .000 .000 .035   .000 .000
G2 
Subs. 
W1e 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.319** .145 .295*
* 
.437
** 
.169
* 
.573** 1 .647**
Sig. (2-tailed) .000 .090 .000 .000 .047 .000   .000
G2 
Subs. 
W2e 
N 138 138 138 138 138 138 138 138
Pearson 
Correlation 
.228** .207* .324*
* 
.424
** 
.368
** 
.492** .647** 1
Sig. (2-tailed) .007 .015 .000 .000 .000 .000 .000   
G2 
Subs. 
W3e 
N 138 138 138 138 138 138 138 138
c0=non-COA, 1=COA. dG2 Age is age at wave 3 because there was increased 
variability. e0=AA genotype, reference group 1=AG genotype. f0=AA genotype, 
reference group, 1=GG genotype. eSubs.=Substance Experimentation. 
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Footnotes 
 
1When correlations between the substance use and CD or ADHD 
indicators were modeled, no improvement in the model fit was observed. For 
methodological reasons, this lack of improvement is expected. The CD and 
ADHD indicators were measured with the same questionnaire while the substance 
use indicators were measured with a different questionnaire. Thus, method 
variance accounts for the need for correlations between the CD and ADHD 
indicators but not with the substance use indicators.  
 
 2All five potential covariates and five covariate-by-predictor interactions 
were tested as main effects on each latent outcome. None of the covariate-by-
predictor interactions were significant, so they were trimmed from the final 
model. 
 
